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SUMMARY 
 
Mouse ES cells can recapitulate, under suitable tissue culture conditions, early 
events in neurogenesis.  As wildtype or genetically modified ES cells can be 
grown in unlimited quantities, their differentiation into neurons represents an 
attractive model for studying the function of genes involved in early development, 
such as those controlling neuronal specification and survival.  A few years ago, 
our laboratory established a robust differentiation protocol leading to the 
generation of well-defined and virtually pure populations of Pax6-positive radial 
glial (RG) cells with a profile and developmental potential characteristic of Pax6-
positive RG cells of the cortex.  Like their in vivo counterparts, these progenitors 
generate homogeneous populations of glutamatergic neurons.  In my thesis 
work, I first addressed the role of Pax6 in the generation, specification and 
developmental potential of RG cells, by analyzing the progeny of ES cells 
isolated from homozygote Pax6-mutant embryos.  I found that while Pax6 is not 
required for the generation of neurogenic RG, it is both sufficient and necessary 
for specifying them into a glutamatergic lineage. RG cells lacking Pax6 express 
genes specifying an interneuron fate, like Mash1, and generate GABAergic 
inhibitory neurons.  These cells die prematurely due to an aberrant over-
expression of the neurotrophin receptor p75.  I could verify these findings in the 
cortex of mutant embryos lacking Pax6.  This work led to new insights as to the 
regulation of neuronal specification and survival during neurogenesis. 
In the second part of my thesis, I used this ES cell-based differentiation system 
to test any potential instructive roles of the 3 neurotrophin tyrosine kinase 
receptors TrkA, TrkB and TrkC, after recombining them into the neuron-specific 
mapt locus.  This approach led to the surprising observations that TrkA and TrkC 
cause neuronal death when not activated by their neurotrophin ligands, whereas 
TrkB does not.  Both the death inducing activity of TrkA and TrkC and the lack of 
death-inducing activity of TrkB were explained by differential distribution of these 
receptors with p75.  The TrkA and TrkC-induced death involves their segregation 
together with p75 in lipid rafts, and the subsequent proteolysis of the latter 
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signals to the apoptotic machinery. By contrast, TrkB is not recruited to lipid rafts 
and it does not result in p75 proteolysis.  Subsequent analyses of TrkA and ngf 
mutants, as well as of embryos lacking both TrkA and p75 receptors confirmed 
the relevance of this novel death triggering mechanism during the development 
of the peripheral nervous system.  These findings also point to a major, and so 
far un-described, difference in the way growth factors regulate the survival of 
neurons in the developing peripheral versus central nervous system.  It is the 
receptors themselves that cause neurons to become growth factor dependent in 
the peripheral, but not in the central nervous system. 
Taken together, my results demonstrate that the differentiation of mouse 
embryonic stem cells into defined neuronal populations represents a useful tool 
allowing observations to be made that are relevant to the development of the 
nervous system.     
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1.INTRODUCTION 
1.1) DEVELOPMENT OF THE PRE-IMPLANTATION EMBRYO 
Mammalian development starts with the fusion of two highly specialized, 
transcriptionally silent germ cells, leading to the formation of a totipotent zygote.  
The zygote, or fertilized egg, undergoes several cleavage events leading to the 
production of an 8-cell morula.  This early embryo is the basis for the first lineage 
decisions, underlined by the instructive role of certain transcription factors.  
During this process, the morula undergoes compaction and polarization to 
transform into the blastocyst, a cavity-filled structure consisting of the founder 
fetal tissue, the epiblast, as well as two extraembryonic structures: The first is a 
layer of epithelium called the trophectoderm (TE), which is specified early on by 
the transcriptional regulators Tead4, a TEA domain family transcription factor and 
its downstream target caudal-related homeobox 2 (Cdx2) (Nishioka et al., 2008). 
Cdx2 protein starts in eight-cell blastomeres and is gradually upregulated in 
future TE cells located toward the exterior of the embryo that finally enclose the 
epiblast and blastocoel.  The second, the primitive endoderm (PrE), is 
consequently specified within the inner cell mass by GATA6 and eventually forms 
a distinct layer at the late blastocyst-stage embryo lining the blastocoel side of 
the epiblast (see Fig.1).   
The epiblast is a transient structure, characterized by the molecular signature of 
3 key transcription factors: Oct4, Sox2 and nanog.  Although Oct4 is ubiquitously 
expressed prior to the segregation of fetal and extraembryonic tissues and as 
early as the unfertilized egg and in the zygote, its expression is then restricted to 
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epiblast cells of the pre-implantation embryo. Later in development, Oct4 is 
expressed by migratory primordial germ cells (PGCs) where it persists 
throughout the formation of the genital ridges in both sexes. A member of a 
group of transcription factors that bind the octamer sequence ATGCAAAT or to 
alternative A/T-rich sites (Saijoh et al., 1996), Oct4 is a crucial component of 
pluripotency, as demonstrated by the compromised ability of mutant embryos to 
generate primitive endoderm and to develop further (Nichols et al., 1998).  
Sox2, a member of the transcription factors containing a high mobility group 
(HMG) DNA binding motif, acts synergistically with Oct4 to regulate target genes, 
often by binding to adjacent sites on their promoters (Chew et al., 2005). 
Interestingly, Sox2 mutant embryos lack Oct4-expressing cells and cannot 
sustain an epiblast component. However, in contrast to Oct4 mutants, the 
formation of the primitive endoderm is not compromised (Avilion et al., 2003).  
The key distinguishing contribution of Sox2 appears to be in maintaining Oct4 
expression. Consistent with this view, enforced expression of Oct4 can rescue 
ES cells from differentiation induced by the loss of Sox2 (Masui et al., 2007).  
Nanog, like Oct4, it is a homeodomain (HD) containing protein. However, its HD 
sequence is not more than 50% homologous to the homeodomains of other 
mouse proteins (Kappen and Ruddle, 1993), indicating that it is a divergent HD 
protein. Nanog protein is first detected in morulae being most obvious in cells in 
the interior of the embryo. 
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Figure 1. Early embryo stages.  Images (top row) and schematics (bottom row) 
of the early stages of embryo development, from the zygote to the late 
blastocyst. 
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High levels of Nanog mRNA persist in the early blastocyst, but its expression 
declines prior to implantation. This dynamic expression pattern could indicate 
that downregulation of Nanog may be important to avoid an uncontrolled 
expansion of pluripotent cells. Following implantation, Nanog mRNA is expressed 
in a subset of epiblast cells with highest levels in the proximal posterior region; 
upon entry into the primitive streak, Nanog mRNA is rapidly downregulated (Hart 
et al., 2004) and is subsequently detected in migratory PGCs and those in genital 
ridges between days 9 and 13 of gestation (Chambers et al., 2003) While at 3.5 
dpc nanog null embryos are indistinguishable from control, when cultured on 
gelatin-coated plate, however, the inner cell mass (ICM) of nanog null blastocysts 
fails to proliferate (Mitsui et al., 2003).     
1.2) ORIGINS AND CHARACTERISTICS OF EMBRYONIC STEM CELLS 
Early work with mouse teratocarcinomas paved the road for the derivation of 
embryonic stem (ES) cell lines (Smith, 2001).  These germ cell tumors in addition 
to multiple differentiated tissues found in benign teratomas also contain 
undifferentiated stem cells, termed embryonal carcinoma (EC) cells (Damjanov 
and Solter, 1974; Dixon and Moore, 1952; Kleinsmith and Pierce, 1964).  The 
discovery that male mice of the SV129 strain have a high incidence of 
spontaneous testicular teratocarcinomas (Stevens and Little, 1954) was key to 
making EC cells amenable to experimental analysis and conditions were soon 
after established to culture these cells in vitro (Kahan and Ephrussi, 1970).  
The cellular origin of teratocarcinoma-forming cells in the pregastrulation embryo 
was shown to be the epiblast (Diwan and Stevens, 1976).  However, as 
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pluripotent cells of the intact early embryo proliferate only for a limited period of 
time, it was not immediately obvious that pluripotent cell lines could be 
established without undergoing a malignant transformation. The striking finding 
that embryonic genital ridges and peri-implantation stage embryos transplanted 
into ectopic sites of adult mice, such as under the kidney capsule, gave rise to 
teratocarcinomas with a high frequency and in strains that did not spontaneously 
produce these tumors (Solter et al., 1970; Stevens, 1970), fueled attempts to 
directly derive pluripotent cell lines from pre-implantation embryos without the 
teratocarcinoma step (Evans and Kaufman, 1981; Martin, 1981).  The success of 
these attempts demonstrated that embryo founder cells can become deregulated 
to support indefinite self-renewal, indicating that they have an intrinsic propensity 
for extended proliferation, a property also shared by EC and germ cells. 
The origin of murine ES cell lines lies in the founder cells of the blastocyst stage 
pre-implantation embryo, known as the epiblast.  ES cell lines established from 
the epiblast of pre-implantation mouse embryos can be propagated under culture 
conditions similar to those used for EC cells, consisting of a feeder layer of 
fibroblasts and the presence of serum. However the principal difference between 
the two is that even after expanded propagation and manipulation in vitro, ES 
cells remain capable of re-entering embryogenesis: EC cells contribute poorly to 
chimeric fetuses when injected into blastocysts and as they are usually 
aneuploid, they cannot undergo meiosis and fail to produce germ cells.  By 
contrast, ES cells retain their full developmental potency as they contribute well 
 13
to chimeras including to germ cells in the genital ridges, thus allowing for further 
germline transmission.   
The landmark of deriving mice from cultured ES cells was reported by the Evans 
laboratory in 1984 (Bradley et al., 1984).  Consistent with their epiblast origin, ES 
cells contribute very poorly to extraembryonic endoderm and almost never to 
trophoblast (Beddington and Robertson, 1989). However, ES cells are self-
sufficient for the generation of the entire fetus, as shown by Nagy and co-workers 
by introducing them into tetraploid recipient embryos, known as the “tetraploid 
complementation assay” (Nagy et al, 1991, 1993) (Figure 2).  In tetraploid 
embryos extraembryonic structures develop normally, whereas the fetal 
component fails to grow. In the chimeras generated between tetraploid embryos 
and diploid cultured ES cells, the entire fetus is derived from the diploid cells, 
demonstrating that they are competent of generating the entire fetus.   
 With regards to establishing culture conditions for ES cells, Smith and Hooper 
demonstrated in 1987 that medium conditioned from the buffalo rat liver cell line 
was able to sustain ES cell propagation and further fractionation of this medium 
identified leukemia inhibitory factor (LIF) as the active component (Smith et al., 
1988).  LIF is a member of the IL6 family of cytokines that signal through receptor 
complexes always including the transmembrane receptor gp130 as a transducing 
subunit, reviewed in (Heinrich et al., 2003).  The signaling cascade downstream 
of this receptor involves the JAK-kinase mediated activation and recruitement of 
the transcription factor STAT3.  While LIF signaling is known to operate in 
multiple tissues, like for example myeloid cells, its output in inhibiting 
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differentiation is unique to the ES cellular context.   Inactivation of LIF or its 
receptor in mice (Stewart et al., 1992; Ware et al., 1995; Yoshida et al., 1996) 
indicated that these molecules are not required for development prior to 
gastrulation.  However, further investigation revealed that these mutations 
compromise the ability of the embryo to undergo diapause, a process whereby 
blastocyst stage embryos are halted from implanting into the uterus until mother 
estrogen levels are restored, typically following the weaning of a preceding litter.  
It is worth noting that almost all mouse ES lines have been derived from 
diapause embryos, since this greatly improves the efficiency of the derivation. 
External signals like LIF support the undifferentiated state of ES cells by 
regulating the “pluripotent genes”.    
There is considerable evidence that a “trinity” of transcriptional regulators, Oct4, 
Sox2 and Nanog, is responsible for maintaining ES cells in a pluripotent state 
both in vitro and in vivo.  Surprisingly, however, Oct4 and Sox2 are also 
responsible for the progressive extinction of pluripotency by activating the 
transcription of FGF4.  This growth factor then acts in an auto- and para-crine 
fashion to propel ES cells towards a general state of differentiation by activating 
downstream signaling through the mitogen-activated protein kinase Erk1/2 
(Kunath et al., 2007). Consequently, ES cells in vitro or epiblast cells in vivo 
lacking FGF4 or components of the Erk1/2 signaling are impaired for lineage 
commitment.   As maintaining ES cells pluripotency means to interfere with their 
developmental progression towards differentiation, Austin Smith and colleagues  
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Figure 2. Schematic of tetraploid complementation assay.  Diploid donor 
embryos at the 2-cell stage are fused to a tetraploid state.  Tetraploid embryos 
develop in vitro to the 4 cell stage.  Subsequently, the zona pellucida is removed 
and tetraploid cells are aggregated in wells together with the diploid ES cells of 
interest, then transferred to pseudopregant females.                             
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demonstrated that genetic disruption or pharmacological inhibition of the 
endogenous FGF4-Erk1/2 signaling axis is sufficient to maintain ES cell 
pluripotency in the absence of exogenous LIF and STAT3 activation (Ying et al., 
2008).  However, growth and viability are impaired under these conditions, either 
as a direct consequence of loss of Erk activity or possibly due to off-target effects 
of the chemical inhibitors. This “collateral damage” can be avoided by inhibition 
of glycogen synthase kinase-3 (GSK3).  The fact that inhibition of the one and 
same signaling axis can capture the pluripotent state of both ES and epiblast 
cells suggests that this pathway may be conserved between mammalian species 
and could therefore facilitate the derivation of authentic ES cells from other 
mammals including humans.   Indeed, using the 2-inhibitors described above the 
first pluripotent rat ES lines were isolated, which were so far impossible to derive 
with conventional means (Buehr et al., 2008; Li et al., 2008).  To date, while ES 
lines have also been isolated from human pre-implantation embryos, the 
necessary culture conditions and even the identity of true human ES cells remain 
unclear.  Moreover, whether the same FGF-Erk signaling axis is operative during 
early human development  is under investigation with considerable efforts, 
including in our own laboratory, focusing on deriving “ground state” hES lines in 
the presence of the 2 inhibitors. 
1.3) NEURAL INDUCTION IN THE EARLY EMBRYO  
Morphogenesis of the peri-implantation mouse embryo proceeds with the 
transformation of the compact inner cell mass (ICM) of the late blastocyst into a 
hollow structure, the egg cylinder: Shortly after implantation, the pro-amniotic 
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cavity forms in the core of the ICM and, by E6.0, the embryonic ectodermal cells 
that line the cavity differentiate into a pseudostratified columnar epithelium. The 
trophectoderm-derived extraembryonic ectoderm undergoes a similar process at 
a slightly later stage. The process by which these changes occur is known as 
cavitation, and similar changes also underline the formation of other hollow 
(tubular) structures that arise from compact primordia, such as the ducts of 
various exocrine glands. Cavitation prepares the embryo for gastrulation, the 
process by which the three germ layers are formed, for review see (Beddington 
and Smith, 1993).   
During gastrulation, primitive ectoderm in the anterior distal quadrant of the egg 
cylinder expands proximally and differentiates to establish the ectodermal germ 
lineage, which gives rise to the non-neural ectoderm, the neurectoderm and the 
neural crest.  
1.3.1) The neurectoderm 
Neuroepithelial progenitor cells of the neurectoderm differentiate to the major cell 
types of the central nervous system (CNS), neurons and glia.  Establishment of 
the neurectodermal lineage has been relatively well characterized at the level of 
gene expression, such that cell differentiation and tissue morphogenetic events 
can be correlated with the temporal regulation of several genes.  
Formation of the neural plate from definitive ectoderm is coincident with up 
regulation of Sox1 (Pevny et al., 1998), and expression of Gbx2 (Wassarman et 
al., 1997). With closure of the neural tube, Gbx2 expression is downregulated 
within the neural epithelium (Wassarman et al., 1997). The undifferentiated 
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neurectoderm, or neuroepithelial progenitors, within the neural tube are 
characterized by the expression of several markers including Sox1, Sox2, nestin 
(Lendahl et al., 1990; Pevny et al., 1998; Wood and Episkopou, 1999), musashi1 
(Kaneko et al., 2000), and N-CAM (neural cell adhesion molecule) (Ronn et al., 
1998; Rutishauser, 1992).  These neuroepithelial cells can either differentiate 
directly into neurons, but more often they do so by generating progenitor 
intermediates: These are the so called radial glial and basal progenitors.  Radial 
glia are more abundant and widely distributed throughout the neural axis, 
whereas basal progenitors, which could be generated directly from 
neuroepithelial cells, or indirectly from radial glial cells, are less abundant in 
rodents, compared to primates, and restricted to the cortical region of the 
telencephalon. Radial glial cells have a bipolar morphology, with one extension 
and broad endfoot sited at the luminal surface and a longer process extending in 
the opposite direction through to the basement membrane adjacent to the pia 
mater, reviewed in (Gotz and Barde, 2005). Similar to neuroepithelial cells, they 
also exhibit an ovoid cell body and have a nucleus situated in the ventricular 
zone, adjacent to the lumen that undergoes interkinetic nuclear migration. 
Ultrastructural studies performed using electron microscopy revealed that radial 
glia function as a substrate/guide upon which newly generated immature neurons 
migrate (Rakic, 1971a, b).   Radial glia display astrocyte characteristics, such as 
electron lucent processes, abundant intermediate filaments, and glycogen 
granules condensed at their end-feet (Choi, 1981; Rakic, 1971a). They also 
express several astrocyte markers, such as astrocyte specific glutamate 
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transporter (GLAST) (Shibata et al., 1997), brain lipid-binding protein (BLBP) 
(Feng et al., 1994), and glial fibrillary acid protein (GFAP) (Levitt and Rakic, 
1980), although in rodents GFAP is not expressed by radial glia (Choi, 1981; 
Sancho-Tello et al., 1995). Radial glia are also immunoreactive to the RC2 and 
Vimentin antibodies (Houle and Fedoroff, 1983; Misson et al., 1988). Together 
these astrocytic features distinguish radial glia from their neuroepithelial 
ancestors. 
1.3.1.1) Neuronal specification 
After induction, the neurectoderm is intricately subdivided, or patterned, with 
respect to both the dorsoventral and anterior-posterior axes, manifested in 
regionalized gene expression within the neural tube. Positional specification in 
the neural tube is determined in response to signals emanating from neighboring 
tissues. For example, concentration gradients of sonic hedgehog (Shh) from the 
notochord and floor plate and BMP4 from the overlying surface ectoderm result 
in dorsal-ventral specification (Sasai and De Robertis, 1997). In conjunction with 
anterior-posterior specification (see Beddington and Robertson, 1999), this 
results in regionally restricted gene expression and restriction of developmental 
potential. For example, the expression of Hoxc5 and Hoxc6 delineates areas of 
posterior neural tube fated to contribute to the spinal cord (Wichterle et al., 2002), 
whereas dorsal-ventral specification can be recognized by expression of genes 
like Nkx6.1 and Olig2 (ventral) and Dbx1, Irx3, and Pax6 (dorsal) (Wichterle et 
al., 2002).  
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1.3.1.2) The homeodomain transcription factor Pax6 
Pax6 is a highly conserved member of the pax gene family, and it encodes a 
protein containing a homeodomain and a paired domain.   In the mouse, Pax6 
begins to be expressed during the eighth day of development in a restricted area, 
the dorsal telencephalon, that gives rise to the cerebral cortex (Walther and 
Gruss, 1991), in a rostro-lateral-high to caudo-medial-low gradient. This is before 
the generation of radial glial cells, the first defined progenitors that can be 
distinguished from other neuroepithelial cells (for review, see (Gotz and Huttner, 
2005).  Pax6 positive radial glial cells are the progenitors of most glutamatergic 
neurons in the rodent cortex (Malatesta et al., 2003).  Pax6 is though to exert its 
patterning activity by directly activating the bHLH neurogenin 1 and 2 genes, 
which in turn inhibit the expression of genes such as Mash1, responsible for a 
ventral telencephalic identity.    In the absence of Pax6, the cerebral cortex is 
markedly smaller (Schmahl et al., 1993), the number of neurons is reduced at 
midgestation (Heins et al., 2002), and the cortex is ventralized (Stoykova et al., 
2000; Toresson et al., 2000; Yun et al., 2001).   However, as cell lineage 
analyses cannot be readily performed in vivo, it remained unclear for a long time 
whether Pax6 controls the generation of radial glial cells, their neurogenic 
potency or specification.  In the first part of my thesis, I used ES cells lacking 
Pax6 to explore their developmental potential by comparison with wildtype ES 
cells (see Results section2.a).   
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1.3.2) The neural crest 
The neural crest, a transient structure present only in vertebrates, is derived from 
the cells located at the border between the non-neural ectoderm and the 
neurectoderm. The formation of this structure involves several signaling events, 
including signals emanating from the newly formed neurectoderm, the non-neural 
ectoderm, as well as the underlying paraxial mesoderm.  The main gene families 
involved in the early steps of induction include, in particular, secreted growth 
factors of the bone morphogenetic protein (BMP), fibroblast growth factor (FGF) 
and Wingless/INT-related (WNT) families, for review see (Knecht and Bronner-
Fraser, 2002).  During neurulation, the border region containing the “pre-
migratory neural crest cells” bends to form the neural folds. Upon closure of the 
neural tube, neural crest cells are localized to the dorsal aspect of the tube, for 
review see (Gammill and Bronner-Fraser, 2003).  Neural crest cells are 
migratory, and depending on the organism and the axial level they initiate their 
migration either from the closing neural folds or from the dorsal neural tube. 
Changes in cadherin-mediated cell adhesion play a role in the process by which 
neural crest cells escape from the neural tube, but the precise nature of that 
involvement remains unclear (Taneyhill, 2008).   It has long been known that 
neural crest cells give rise to an amazingly diverse set of derivatives, including 
smooth muscle and cartilage, and indeed most of the peripheral nervous system 
(PNS), including neurons and non-neuronal cells (Le Douarin, 1982). 
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1.4) TROPHIC SUPPORT OF NERVOUS SYSTEM SURVIVAL 
Early work with chick and amphibians demonstrated that interactions of neurons 
with their environment are crucial for their survival.  As early as 1909, Shorey 
reported that unilateral ablation of the limb bud of the chick resulted in severe 
hypoplasia of both the ipsilateral sensory ganglia and spinal cord, including the 
motor column in the ventral horn (Shorey, M. L. 1909. J. Exp,. Zool. 7: 25-63).   
These results were later replicated by Hamburger (1934) and set the foundation 
for the target-derived neurotrophic theory.  The purification of nerve Growth 
Factor (NGF), first from sarcoma lines and subsequently from snake venom 
(Cohen and Levi-Montalcini, 1956, 1957; Cohen et al., 1954), followed by the 
extraordinary demonstration that NGF has all the characteristics of a target-
derived molecule necessary for the survival of defined populations of neurons 
during development (Levi-Montalcini, 1966), allowed the understanding of the 
target-derived neurotrophic theory at the molecular level. Not only is NGF 
expressed in the tissues that are innervated by NGF-responsive neurons and 
axons (Heumann et al., 1984), but also the degree of its expression is 
proportionate to the density of innervation (Korsching and Thoenen, 1983; 
Shelton and Reichardt, 1984). NGF is now well recognized to be required for the 
survival of all sympathetic and many sensory neurons, as demonstrated by the 
death of these neurons after axotomy, and the ability of NGF to rescue them, or 
prevent the death of sympathetic neurons whose nerve endings have been 
destroyed by 6-hydroxy-dopamine at birth, in a model known as chemical 
sympathectomy (Levi-Montalcini et al., 1975).  
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Neurotrophic factors comprise several gene families of ligands and their 
receptors, with Neurotrophin and GDNF (Glial cell line Derived Neurotrophic 
Factor) families being the best characterized with regard to their activity as target 
derived trophic molecules supporting the survival of neurons in the peripheral 
nervous system.  
1.4.1) The Neurotrophin family 
Neurotrophins (NGF, BDNF, NT3 and NT4) and their receptors are components 
of a signaling system known to play major and diverse functional roles in the 
nervous system of vertebrates (Reichardt, 2006). They signal by activating 
specific Trk receptors expressed at the cell surface as progenitors exit the cell 
cycle and begin to grow axons (Bibel and Barde, 2000). The Trk receptors 
belong to the family of receptor tyrosine kinases, and three trk genes have been 
identified in mammals. The TrkA proto-oncogene was first identified as an NGF 
receptor (Kaplan et al., 1991; Klein et al., 1991) followed by TrkB and TrkC (for 
review, see (Barbacid, 1994). NGF is the preferred ligand for TrkA, BDNF and 
NT4/5 are preferred for TrkB, and NT3 for TrkC (Barbacid 1994). These 
specificities are not absolute, as NT3 is also a ligand for TrkA and TrkB (Figure 
3). Binding of the neurotrophins to the Trk receptors leads to receptor tyrosine 
phosphorylation (for review, see (Friedman and Greene, 1999). This triggers the 
activation of pathways leading to the prevention of programmed cell death and 
neuronal differentiation.  
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Decades of work with avian and rodent embryos has clarified some of the basic 
functions of the neurotrophin signaling system, such as the ability of target 
derived neurotrophins to regulate the survival of large numbers of neurons in the 
peripheral nervous system (PNS) including most sympathetic and sensory 
neurons (Reichardt, 2006; Bibel and Barde, 2000). The exquisite ability of 
neurotrophins to act as messengers between neurons and their targets is 
explained by their selective expression pattern: Trk receptors are expressed by 
sensory and sympathetic neurons (Tessarollo et al., 1993), while neurotrophin 
ligands are primarily localized in the target areas innervated by their responsive 
axons (Davies, 1994) and released in limiting amounts.  TrkA is expressed in all 
sympathetic neurons, as well as in small and middle size dorsal root gangion 
neurons. Mice mutant for ngf or TrkA genes exhibit loss of all sympathetic 
neurons (Fagan et al., 1996) and of the selective DRG neuronal populations 
expressing TrkA.  Similarly, TrkC is expressed in large size proprioceptive 
neurons of the DRG, which are lost in TrkC or nt3 mutants. Unexpectedly, NT3 
was also shown to be required for the survival of about half the number of cranial 
sympathetic neurons. This conclusion was reached both with antibodies blocking 
the function of NT3 (Gaese et al., 1994; Zhou and Rush, 1995) and with nt3−/− 
mutants (Ernfors et al., 1994; Farinas et al., 1994). There is now good evidence 
that NT3 exerts its survival action through TrkA (Brennan et al., 1999; Wyatt et 
al., 1997).  A small population of DRG mechanoreceptors innervating Merkel 
cells and deep-hair cells express TrkB and depend on target derived BDNF and  
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Figure 3. Schematic structures of Trk receptors.  
In their extracellular domains, three tandem repeat leucine-rich motives are 
flanked by two cystein clusters. The main contacts between the Trk receptors 
and their ligands occur within two Ig-like C2 type domains. The intracellular, 
enzymatically active, tyrosine kinase domains are highly conserved among the 
three Trk receptors.   
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NT4 respectively for their survival (Carroll et al., 1998). In the PNS, TrkB is also 
expressed in the vestibular, petrosal and nodose ganglia, often together with 
TrkC, and its activation is required for the survival of these neurons (Ernfors et 
al., 1994; Jones et al., 1994; Silos-Santiago et al., 1997).   
In addition to having a pro-survival role for PNS neurons, neurotrophins are also 
required for inducing the expression of genes required for the establishment of 
proper connections.  This is best exemplified by the requirement of NT3 signaling 
for the induction of the ETS transcription factor ER81 in proprioceptive sensory 
neurons, which is necessary for the formation of the appropriate connections to 
motor neurons (Patel et al., 2003).   
In the CNS, only very few neurons express TrkA (mostly the basal forebrain 
cholinergic neurons), whereas by contrast TrkB is expressed at comparatively 
high levels by the majority of CNS neurons.  TrkC is typically expressed in the 
CNS early in development and at lower levels (Tessarollo et al., 1993). The view  
that neurotrophin dependency for survival would also be applicable to neurons of 
the central nervous system is mainly based on early classical observations that 
motorneurons die after removing the target cells they innervate (Shorey 1909; 
Hamburger, 1934).  This view was further supported after it was realized that the 
death of motor-neurons can be prevented after axotomy by neurotrophins, such 
as BDNF applied to the cut end of the motor axons (Sendtner et al., 1992).  
However, it was soon after realized that motor neuron survival is only supported 
by neurotrophins in lesion paradigms such as axotomy or limb removal (see 
above). Doubts about the survival promoting role of neurotrophins in the CNS 
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during NORMAL development begun to arise following the generation of the first 
bdnf knockout animals.  They showed very little, if any, cell death in the CNS, in 
marked contrast to what had been previously observed in the PNS following NGF 
removal experiments.    
In addition to Trk receptors, all neurotrophins also bind to p75, a member of the 
TNF family, which lacks catalytic activity. As other members of this family, p75 
has a death domain in its cytoplasmic tail and signals both in ligand dependent 
and independent fashion by recruiting a number of interacting molecules.  
Although p75 over-expression or activation by neurotrophins classically results in 
cell death, the outcome of its activation often varies considerably depending on 
the cellular context.  P75 is often co-expressed in the same cell together with a 
Trk receptor, where it has the capacity to modulate neurotrophin signaling (for 
review see (Barker, 1998). 
1.4.2) The glial cell line-derived neurotrophic factor family 
Members of the glial cell line-derived neurotrophic factor (GDNF) family ligands 
(GFLs) are crucial for the development and maintenance of distinct sets of 
peripheral neurons, as well as specific non-neuronal cells, for reviews see 
(Airaksinen and Saarma, 2002; Baloh et al., 2000; Enomoto, 2005; Takahashi, 
2001).  Four different ligand-receptor pairs exist in mammals, GDNF-GFRα1; 
neurturin (NRTN)-GFRα2; artemin (ARTN)-GFRα3; and persephin (PSPN)-
GFRα4. For all these pairs, signaling requires the RET tyrosine kinase receptor.  
In any given RET/GFRα receptor complex, two distinct tasks, namely ligand 
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binding and intracellular signaling, are performed separately by GFRα and RET, 
respectively (Figure 4). Mice deficient for GFLs, GFRαs or Ret have been shown 
to exhibit a number of neuronal deficits, establishing these ligands as a novel and 
bona fide family of neurotrophic factors acting in vivo (Baloh et al., 2000). In 
addition to nervous system development, they play crucial roles in the 
development of the urogenital system, including the kidney and testis (Meng et 
al., 2000; Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996; 
Schuchardt et al., 1994).  
Highlighting the importance of this signaling system, inactivating mutations in the 
Ret gene have been identified as one of the major causes of Hirschsprung 
disease (Edery et al., 1994), characterized by congenital absence of enteric 
neurons in the digestive tract. The development of the enteric nervous system 
relies on the proper migration, proliferation and differentiation of neural crest cells 
emanating from the dorsal region of the embryo at the vagal, sacral and trunk 
levels. Mice deficient for GDNF, GFRα1 or RET lack all neurons in the gut distal 
to the stomach and die within 24 h after birth (Schuchardt et al., 1994; Moore et 
al., 1996; Pichel et al., 1996; Sanchez et al., 1996; (Cacalano et al., 1998); 
Enomoto et al., 1998). In GDNF signaling mutants, the initial deficits are 
discernible as early as embryonic day (E) 10.5, when EN precursors begin to 
enter the midgut (Taraviras et al., 1999). 
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Figure 4. Schematic structures of GDNF family ligand (GFL), GDNF family 
receptor alpha (GFRa) and RET proteins.  
The GFL dimmer first binds a GFRa receptor that is attached to the membrane 
with a GPI-anchor that keeps the receptor in lipids rafts. GFLs are cystine- knot 
proteins forming a distant subgroup in the TGF-b superfamily (Eigenbrot and 
Gerber, 1997), whereas GFRa s are composed of three homologous globular 
GFR domains (D1–D3) that have a novel fold [Leppänen et al., 2004]. The 
vertebrate RET extracellular domain contains a single cysteine-rich domain 
(CRD). A calcium-binding site in RET is important for its activation. 
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All post-ganglionic sympathetic neurons are located in close proximity to 
vertebral bodies, meaning that the axons of these neurons have to travel across 
significant distances to reach their target tissues. During this process, 
sympathetic neurons target blood vessels as intermediate guidance routes and 
extend their axons along these vascular pathways. Recent studies have provided 
evidence that ARTN signaling via GFRα3/RET is the central regulator for the 
growth of sympathetic axons in alignment with blood vessels. This migration and 
axon growth are severely impaired in animals lacking ARTN signaling ((Nishino 
et al., 1999); Enomoto et al., 2001; (Honma et al., 2002) followed by increased 
death of sympathetic neurons later in development. Because a failure in axon 
growth precedes this cell death, it has been suggested that the abnormal cell 
death occurs because of the unavailability of some target-derived survival factor, 
such as nerve growth factor (NGF). Therefore, it seems that during sympathetic 
neuron development, GFL and NGF provide signals sequentially to support 
neuronal migration/axon growth and cell survival, respectively.   Experimental 
evidence also indicates that GFL signaling is also required for the survival of 
parasympathetic neurons during development:  At early stages, signaling of 
GDNF via GFRα1/RET is essential for the proper migration and proliferation of 
cranial parasympathetic neuron precursors (Enomoto et al., 2000; (Rossi et al., 
2000)).   Later in development, NRTN signaling via GFRα2/RET is required for 
the survival of parasympathetic neurons and innervation of target organs. 
Perturbations in GDNF family signaling also affects different populations of 
sensory neurons.  GDNF deficient mice exhibit a substantial loss of neurons in 
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the petrosal ganglia, which innervate the carotid body.  The same neuronal 
population is affected by a BDNF loss-of-function mutation, indicating 
requirements for both GDNF and BDNF in the development of these 
viscerosensory neurons (Erickson et al., 2001).  The biological roles of the GDNF 
ligands in trigeminal and dorsal root ganglion neurons is less obvious, as they 
seem to function in the maintenance of these neurons postnatally.  In rodents, 
approximately two-thirds of the neurons in the spinal sensory ganglia express 
TrkA at birth. As they mature, half these neurons lose their TrkA expression and 
begin to express RET and IB-4 (Molliver et al., 1997). In adult animals, the 
population of Ret-expressing neurons includes both large and small-sized cells 
expressing GFRα1–3 receptors in complementary or overlapping patterns 
(Bennett et al., 1998; Orozco et al., 2001). Adult neurturin-deficient mice lose 
approximately 50% of their GFRα2-expressing DRG neurons (Heuckeroth et al., 
1999).   Similarly to the neurotrophins, the prosurvival activity of GDNF family 
members is almost exclusive to peripheral neurons and neural crest derivatives.  
By contrast, CNS neurons do not depend during development on these or any 
other soluble factors known to date, in order to survive and to establish proper 
innervation patterns.  However, GDNF can have other effects on central neurons.  
For example, GDNF synthesized first in the plexus of the developing limb and 
later on in two muscles of the limb, the cutaneous maximus and the latissimus 
dorsi, is necessary for the induction of the transcription factor Pea3 in the motor 
neurons innervating these targets, which in turn regulates their correct pattern of 
connectivity (Haase et al., 2002).  In GDNF knockout animals, the induction of 
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Pea3 fails, and the projections of the relevant motor neurons are misrouted into 
the spinal cord (Haase et al., 2002).   
1.5) NEURONAL DIFFERENTIATION OF EMBRYONIC STEM CELLS 
As amply demonstrated with the mouse system, ES cells cultured in vitro, even 
for extended periods of time, retain the capacity of re-entering embryogenesis, 
and share with epiblast cells the ability to differentiate into cell types representing 
all 3 definite germ layers.   A realistic goal for neurobiologists interested in 
developmental mechanisms in vertebrates is then to use ES cells as a tool to 
delineate lineage commitment decisions and to generate in vitro relevant 
populations of neurons.  Such undertakings, together with the ability to introduce 
specific genetic alterations, create the possibility of generating in vitro models for 
studying early steps of neural development that are difficult to access in vivo, 
because of limited quantity of materials, cellular heterogeneity and 
developmental gradients.   
In order to differentiate ES cells, the cell culture medium is altered such that LIF 
and BMP/serum are replaced by alternative inductive signals. It was early on 
appreciated with embryonic carcinoma (EC) cells (Jones-Villeneuve et al., 1982) 
and later with ES cells (Bain et al., 1995) that culturing them as free-floating 
aggregates, known also as embryoid bodies, without the addition of LIF and in 
the presence of retinoic acid and serum, resulted in a differentiation towards the 
neuronal lineage. Modifications to this protocol were developed soon after in 
which exposure to retinoic acid was minimized and neural precursor populations 
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could be induced and subsequently enriched by selective survival in a serum free 
basal media (Okabe et al., 1996). Other distinct protocols were developed which 
rely on co-culture with a stromal cell line PA6, or exposure to conditioned media 
(Kawasaki et al., 2000; Rathjen et al., 1999). Ying and colleagues developed an 
alternative protocol in which Sox1 expressing neuroepithelial cells can be 
generated in adherent monolayer at higher efficiencies (>60%) in a process that 
requires FGF signaling (Ying et al., 2003). However, this protocol, like the 
preceding ones, results in only partial neural induction and relies on sorting of 
neurons from a cell mixture.  In addition, the neuronal population obtained 
represents a heterogeneous sum of very different subtypes of neurons, 
presumably due to the diversifying effect of FGF.    
More recently, efforts have been directed towards restricting the ES cell-derived 
progeny to specific neuronal types.  In particular, work from the Jessell laboratory 
demonstrated that motor neurons can be generated from ES cells by treatment of 
RA-exposed aggregates to diffusible sonic hedgehog (shh), a morphogen known 
to play a crucial role in vivo during motor neuron specification (Wichterle et al., 
2002).  Work from the Vanderhaeghen laboratory demonstrated that in the 
absence of any morphogens, shh inhibitors facilitated the differentiation of ES 
cells into an array of neurons with a forebrain-like identity.  Interestingly, ES cell-
derived neurons corresponding to distinct cortical subtypes appeared in vitro 
through a coordinated sequence, as observed in vivo (Gaspard et al., 2008). 
We recently described an ES cell-based culture system that closely recapitulates 
the early steps of cortical neurogenesis in vitro.  This comparatively simple, but 
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robust differentiation protocol, based on the treatment of ES cell aggregates with 
retinoic acid, leads to the generation of neural progenitors identified as Pax6-
positive radial glial (RG) cells (Bibel et al., 2004 and Bibel et al., 2007). These 
progenitors undergo few cell divisions and then go on to terminally differentiate 
into glutamatergic neurons, the progeny of Pax6-positive RG cells in the 
developing mouse cortex (Malatesta et al., 2003).  Transplants of these cells 
have revealed some developmental restrictions (Plachta et al., 2004). Upon 
injection in chick embryos they generate neurons in the spinal cord and dorsal 
root ganglia (DRG). However, only in the spinal cord do they acquire an 
appropriate regional identity. This contrasts with the injection of non RA-treated 
ES cell aggregates that are able to generate both spinal cord neurons and DRG 
neurons (Plachta et al., 2004). Thus, our in vitro differentiation protocol appears 
to restrict the global CNS–PNS differentiation potential of ES cell derived 
progenitors to a CNS fate.  The success of this procedure, the first to allow the 
reproducible generation of well-defined and homogeneous progenitor 
populations, as opposed to a mixture of different neural types, is thought to lie on 
the selection of rapidly dividing ES cells. As it is well recognized that ES cells 
slow down their rate of division as they start to differentiate, a uniformly 
pluripotent ES cell population can be maintained by simply splitting ES cells 
frequently, thereby diluting out cells that have begun to differentiate.  We now 
understand (see above) that this is due the fact that 2 of the key pluripotency 
genes also regulate the expression of FGF4 that causes differentiation.  
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 Figure 5.  Outline of ES cell neuronal differentiation protocol.  Briefly, 
rapidly dividing ES cells are selected on feeders, then cultured in feeder free 
conditions in the presence of LIF.  ES cells are subsequently cultured as free-
floating aggregates in the absence of LIF and treated with retinoic acid to induce 
neural fate.  Following dissociation of aggregates, Pax6-positive radial glial cells 
are obtained, which rapidly go on to terminally differentiate into glutamatergic 
neurons.  
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2. RESULTS 
In the first part of my thesis I investigated the role of the transcription factor Pax6 
in the specification of cortical progenitors during development, using ES cells 
lacking Pax6 and comparing their developmental potential to that of wildtype ES 
cells.  In the second part of the thesis, I used ES cells engineered to expressed 
the neurotrophin receptors TrkA, TrkB or TrkC from a neuron-specific locus, in 
order to study possible instructive functions of these receptors in developing 
neurons.     
2.1) THE ROLE OF PAX6 IN NEURONAL SPECIFICATION 
Radial glial (RG) cells expressing the transcription factor Pax6 are the 
progenitors of most glutamatergic neurons in the developing cortex of the mouse 
(Malatesta et al., 2003).  Early work revealed the essential role of Pax6 in cortical 
development, as the small-eye “Sey” mutants lacking functional Pax6 protein 
display an array of neural defects, including a massive reduction in the number of 
neurons in the cortex. Pax6 begins to be expressed at embryonic day 8 in the 
pallium, before the generation of RG progenitors (Walther and Gruss, 1991).  As 
lineage analyses are difficult in vivo at such early developmental stages, the role 
of Pax6 in RG generation and specification remained elusive.  In the first part of 
my thesis, I used ES cells lacking Pax6 (thereafter referred to as Sey or mutant 
cells) and compared their developmental potential to that of wildtype cells.                 
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2.1.1) Pax6 mutant embryonic stem cells generate mash1-positive radial 
glial cells 
Two distinct ES cell lines isolated from the blastocysts of homozygote Sey 
mutants and wild-type (WT) mouse ES cells were cultured following a protocol 
involving treatment of ES cell aggregates with retinoic acid (RA) to trigger neural 
commitment (Bibel et al., 2004). Similar to WT ES cells after RA treatment, 
mutant cells also uniformly expressed the neuroepithelial antigen nestin as well 
as RC2 and GLAST, an astrocyte-specific glutamate transporter, but not Pax6. 
Both WT and mutant aggregates were negative for Pax7, Isl1, and MNR2 that 
mark spinal cord progenitors (data not shown; Plachta et al., 2004) but both 
expressed Emx2 (Figure 6A) at similar levels (Figure 6B), a marker for cortical 
progenitors (Simeone et al., 1992). Like previously reported for Pax6 (Bibel et al., 
2004), Emx2 was also downregulated during the course of neuronal 
differentiation (Figure 6B). Following dissociation of RA-treated aggregates, 
mutant cells generated spindle shaped cells characteristic of RG cells (Bibel et 
al., 2004). However, they all had larger cell bodies than WT RG cells and one 
branched process (Figure 6C), a morphology reminiscent of RG cells in the 
ventral telencephalon. Mutant ES cells generated RC2- and GLAST-positive 
progenitors with equal efficiency compared with WT ES cells (Figure 6D) and 
most expressed the basic helix-loop-helix (bHLH) transcription factor Mash1 that 
marks subventricular zone progenitors of the ventral telencephalon (Porteus et 
al., 1994), while Emx2 expression was maintained (Figure 6D). Significantly 
higher levels of Mash1 were detected in mutant than in WT progenitors (Figure 
6E), and Mash1 was not detected in neurons (Figure 6E). RT-PCR analysis also 
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revealed that Ngn2, a marker of dorsal telencephalic progenitors, and Tbr1, a 
marker of dorsal telencephalic neurons, were present in the WT ES-derived 
progenitors and neurons, respectively (Figure 6F). By contrast, Ngn2 and Tbr1 
were barely detectable in mutant progenitors and neurons, respectively (Figure 
6F). Loss of Pax6 Causes a Neurotransmitter Switch While neurons derived from 
WT ES cells express the vesicular glutamate transporter (vGLUT1) as early as 4 
days in vitro (Figure 7A), neurons generated from mutant ES cells expressed 
instead typical markers of GABA-ergic neurons such as the vesicular transporter 
vGAT (Figures 7B and 7C) and glutamic acid decarboxylase (GAD) (Figures 7B 
and 7D). These characteristics were already apparent at day 4 (data not shown) 
and by day 6, over 80% of the neurons could already be labeled with both 
markers (Figures 7C and 7D). Subpopulations of GABAergic neurons can be 
identified on the basis of the expression of the calcium binding proteins 
(DeFelipe, 1997; Kubota and Kawaguchi, 1994), and the majority of the mutant 
neurons were positive for calretinin (Figures 7B and 7E), while calbindin-positive 
neurons were not observed (data not shown). A small number of glutamatergic 
WT neurons also expressed calretinin (Figures 7B and 7E). Western blot 
analyses confirmed that, unlike WT neurons, mutant neurons express vGAT and 
higher levels of calretinin compared to WT cells (Figure 7F). To determine 
whether the switch of neurotransmitter phenotype can be causally attributed to 
the lack of Pax6, we reintroduced it in mutant ES cells with a retrovirus encoding 
either Pax6-IRES-GFP or IRES-GFP alone (Hack et al., 2004). Because only few 
cells are infected and non-infected cells die prematurely (see below), we co-
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cultured mutant with WT progenitors. While at day 6 most neurons derived from 
progenitors infected with GFP alone expressed vGAT (Figure 7G), the vast 
majority of the neurons derived from Pax6-infected progenitors did not (Figure 
7G), but expressed vGLUT1 instead (Figure 7H). 
2.1.2) Transplantation of embryonic stem cells in the chick telencephalon 
We next tested the differentiation potential of ES cells and of ES cell-derived 
neurogenic progenitors after transplantation in the chick telencephalon. At about 
E1.5 (12-somite), most of the cells were removed in the areas corresponding to 
either the prospective ventral or dorsal telencephalon (see Figure 8A). 
Aggregates of RA-untreated (‘‘naive’’) ES cells or of progenitors (RA-treated WT 
or mutant ES cells) were then used to fill up these areas and their progeny was 
analyzed 8 days later. To facilitate the visualization of ES cell-derived neurons, 
WT and mutant ES cell lines were used with a reporter GFP cDNA inserted in the 
tau locus (Bibel et al., 2004). In agreement with the in vivo and in vitro lineage of 
Pax6-positive RG cells, almost all WT progenitors transplanted in the prospective 
dorsal telencephalon differentiated into glutamatergic neurons, as assessed by 
the expression of the vesicular glutamate transporter (vGLUT1) (73.9% ± 3.12), 
with only a small fraction expressing the vesicular GABA transporter (vGAT) 
(2.1% ± 0.92) (Figure 8B). To test whether the environment can override the 
intrinsic commitment of the Pax6-positive progenitors to a glutamatergic fate, we 
also transplanted WT RA-treated ES cells in the prospective ventral 
telencephalon of the developing chick, a region where GABAergic neurons are 
normally generated. While these cells successfully differentiated into neurons 
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that populated the ventral telencephalon, the majority of these neurons 
expressed vGLUT1, and only a few expressed vGAT (vGLUT1 56.4% ± 4.94; 
vGAT 5.4% ± 2.81) (Figure 8C). In addition, with the exception of a few cells, 
they failed to follow a tangential migratory route, as ventrally generated neurons 
do, and to populate the cortex. The control experiment with RA-untreated, naı¨ve, 
and pluripotent ES cell revealed that mouse ES cells are able to respond to the 
environmental cues of the ventral telencephalon. They differentiated mostly into 
GABA-ergic neurons (vGAT 66.9% ± 3.71; vGLUT1 10.1% ± 2.44), and most of 
them successfully migrated tangentially into the cortex (Figure 8D). Mutant RA-
treated ES cells transplanted in the prospective ventral telencephalon were also 
able to integrate into the host environment and to differentiate into neurons. 
However, by contrast with WT RA-treated ES cells, almost all of these neurons 
expressed vGAT (vGAT 92.7% ± 1.27; vGLUT1 1.0% ± 0.82). In addition, the 
cells followed a tangential migratory route and populated the cortex (Figure 8E). 
Mutant RA-treated ES cells transplanted in the prospective dorsal telencephalon 
exhibited a clustering behavior, reminiscent of Pax6 mutant cells in the WT 
cortex of mice (Talamillo et al., 2003), and integrated much less successfully in 
the cortex (Figure 8F). Many cells expressed very low levels of GFP and 
exhibited apoptotic features, such as a pyknotic nuclear morphology (data not 
shown), and virtually all survivors differentiated into vGAT-positive neurons 
(vGAT 93.0% ± 2.6; vGLUT1 0%).  
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2.1.3) Neurotrophin receptor expression and death of neurons derived from 
Pax6-mutant embryonic stem cells  
ES cell-derived mutant neurons failed to develop normal processes as revealed 
with b-III tubulin antibodies (Figure 9A). They remain thinner, less branched, and 
shorter than those of WT neurons (Figure 9A), and by day 8, the cell bodies 
exhibited features of apoptotic death (Figure 9A), including a pyknotic nuclear 
morphology (Figure 9A, insert). With regard to cell death, no significant 
differences between WT and mutant cultures were observed before day 6 (Figure 
9B). However, at day 7 a significant fraction of mutant neurons became 
apoptotic, and they were all dead by day 8 (Figure 9B). These results were 
obtained with two independent clones of Pax6 mutant ES cells. As the 
neurotrophin receptor p75NTR has recently been shown to cause the death of 
processes and of cell bodies when overexpressed in ES cell-derived neurons 
(Plachta et al., 2007), we examined its levels in both WT and mutant progenitors 
(Figure 9C). While p75NTR was rapidly downregulated in WT neurons during 
differentiation of the progenitors (see Bibel et al., 2004), it remained expressed at 
high levels in mutant neurons (Figure 9C). By contrast, Trk receptors, that are 
activated by neurotrophins to allow the survival of developing neurons in the 
peripheral nervous system (Huang and Reichardt, 2003), failed to be expressed 
at detectable levels (Figure 9C). To test if the death of the mutant neurons is a 
direct consequence of the lack of Pax6, we reintroduced it in mutant ES cells 
(see above). As only between 10 to 30 cells per 5 3 105 cells were infected, we 
again co-cultured the neurons derived from infected RG cells with WT neurons to 
overcome potential problems resulting form low density cultures. Mutant RG cells 
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infected with GFP alone generated neurons (Figure 9D) with short, unbranched 
processes, a morphology characteristic of mutant neurons (see above). After 8 
days in vitro, these neurons lost their processes and the vast majority of them 
died (survival rate 1.5% ± 0.69) (Figures 9D and 9E). By contrast, mutant RG 
cells infected with Pax6 generated neurons with longer processes, similar to that 
of wild-type cells (Figure 9D). In addition, these cells survived (survival rate 
75.4% ± 4.9 at day 8) (Figure 9E) and could be maintained in vitro as long as WT 
neurons. With time, they developed into mature neurons with long processes and 
very extensive branching patterns (Figure 9D). 
2.1.4) Neurotrophin receptor expression and cell death in the Pax6-mutant 
cortex  
In view of these results, we examined the cortex of Pax6 mutant (Sey/Sey) 
animals for the expression patterns of p75NTR and TrkB as well as for evidence 
of cell death. In the WT cortex, p75NTR expression was restricted to the subplate 
neurons (arrows) as previously reported (Allendoerfer et al., 1990) (Figure 10A). 
By contrast, p75NTR was ectopically expressed in the mutant cortex at E12, 
particularly in the marginal zone and upper cortical layer (Figure 10A). The 
ectopic expression of p75NTR in the mutant cortex did not persist until later 
developmental stages, and already by E14, its expression pattern was similar to 
that of the WT cortex (Figure 5A). TrkB was present in the WT cortex at E12, and 
its expression levels increased by E14 (Figure 10A). Although neurofilament 
staining indicated the presence of neurons in the mutant cortex, almost no TrkB 
expression was detected, both at E12 and at E14 (Figure 10A). This defect was 
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restricted to the cortex, and ventral structures, where Pax6 is not expressed 
(Stoykova and Gruss, 1994), exhibited normal TrkB expression (Figure 10A, 
yellow arrow). In addition, the mutant cortex contained significantly more 
apoptotic cells at E12 compared to WT, as assessed by TUNEL (Figure 10B) and 
active-caspase 3 staining (Figure 10B). The distribution of apoptotic profiles 
corresponded to cells ectopically expressing p75NTR, predominantly in the 
cortical plate and marginal zone (mutant 78.7% ± 7.4; WT 29.9% ± 5.8, Figure 
10C). Notably, increased cell death in the mutant cortex was less pronounced at 
later developmental stages (E14, see Figure 10B), and both the ectopic 
expression of p75NTR and increased apoptosis were restricted to the cortex and 
were not observed in the ventral telencephalon (Stoykova and Gruss, 1994; 
Figure 10D). In addition, ectopic expression of p75NTR and of active caspase 3 
were also detected in the olfactory bulb-like structure (OBLS) (indicated by 
arrows in Figure 10D), a structure formed near the lateral pallium of the Sey 
cortex (Jimenez et al., 2002; Stoykova et al., 2003). Immunostaining of 
E12WTand mutant brain sections for vGAT, GAD, and Calretinin revealed that 
the mutant cortex contained about 3-fold more neurons expressing these 
markers compared to WT littermates that, as expected, contained only few 
GABAergic neurons at this stage (Figures 11A and 11B). These GABAergic 
neurons were primarily localized in the cortical plate of the Sey cortex. Only very 
few cells expressed Calbindin in the mutant cortex, as observed in the WT cortex 
(data not shown). The majority of these GABAergic neurons in the mutant cortex 
showed signs of apoptosis, as many vGAT-positive cells expressed high levels of 
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p75NTR, co-localized with active caspase 3, and exhibited nuclear pyknosis 
(Figure 11C). As p75NTR expression could also be detected close to the 
ventricular zone in the Pax6 mutant cortex (for example see arrow in Figure 7C), 
we performed co-immunostainings for p75NTR and the RG marker Glast and for 
doublecortin, an antibody that recognizes newborn neurons. Only few Glast-
positive cells co-localized with p75NTR, while the majority of p75NTR-positive 
cells near the ventricular zone expressed doublecortin (data not shown). Taken 
together, these results indicate that, while cortical RG cells remain largely 
unaffected in the mutant, GABAergic neurons upregulate p75NTR soon after 
their birth and undergo apoptosis. Staining for the nuclei and for doublecortin 
indicated that the number of newborn neurons was significantly increased at E12 
in the mutant cortex (Figure 11E) and that many doublecortin-positive cells were 
located in the vicinity of the ventricular zone, as indicated by the arrows (Figure 
11D). At midgestation (E14), the number of doublecortin-positive cells in the 
mutant cortex was decreased compared to WT by about 40%. This finding is in 
line with the increased number of GABAergic cells in the early mutant cortex and 
with recent findings indicating that the loss of Pax6 prevents the reentry of 
cortical progenitors into S-phase, thus resulting in a greater proportion of 
differentiating neurons at E12.5 (Quinn et al., 2007). 
2.1.5) Downregulation of p75NTR decreases neuronal death in vitro and in 
vivo 
To test if the death of GABAergic neurons is due to the over-expression of 
p75NTR, mutant ES cells were electroporated with three different shRNA 
 45
constructs directed against mouse p75NTR mRNA and with a scrambled 
sequence with no match in the mouse genome. Stable clones were selected 
using neomycin and analyzed for p75NTR downregulation by western blot 
analysis (Figure 12A). While mutant neurons expressing the scrambled 
sequence died prematurely (data not shown), mutant neurons expressing shRNA 
against p75NTR survived for at least 30 days (Figure 12B). In addition, they 
uniformly expressed vGAT (Figure 12C), indicating that downregulation of 
p75NTR did not have any effect on the identity of the mutant neurons. Moreover, 
mutant neurons expressing sh-p75NTR seem to form synaptic contacts, as 
indicated by the distribution of synaptophysin immunoreactivity (Figure 12C). We 
also noted that those mutant neurons that managed to survive in the chick 
telencephalon downregulated the levels of p75 expression (see Figure 13). The 
reasons for the reduced expression of p75NTR after transplantation are unclear. 
To assess the role of p75NTR overexpression in the death of GABAergic 
neurons in the Pax6 mutant cortex, heterozygote Sey/+ mutants were crossed 
with p75NTR heterozygote animals (von Schack et al., 2001). Homozygote 
double mutants contained significantly fewer TUNEL-positive cells in the cortex 
at E12 compared to Pax6 homozygote mutants that lacked only one copy of 
p75NTR (Sey/Sey;p75+/-) or that were WT for p75NTR (Sey/Sey) (Figure 12E). 
This reduction in cell death was accompanied by increased survival of 
misspecified GABAergic neurons resulting in increased numbers of GAD-positive 
neurons at E14 in the Sey/Sey;p75-/- cortex compared to WT and 
Sey/Sey;p75+/- (Figure 12E). While most GAD-positive neurons were localized in 
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the cortical plate and marginal zone of the double mutant, far fewer were 
observed in the WT cortex, most of which were localized in the subventricular 
zone (Figure 12E, arrows) and only few in the marginal zone (Figure 12E, 
arrowheads). 
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 Figure 6 
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Figure 6. Loss of Pax6 Impairs the Specification, Not the Generation, of RG 
Cells from ES Cells 
 
(A) RA-treated, WT, and mutant aggregates express the neuroepithelial 
marker Nestin, its modification recognized by RC2, the RG marker Glast, 
and the transcription factor emx2. Pax6 is not detected in mutant 
aggregates. 
(B) WT and mutant RA-treated aggregates express Emx2, as shown by 
western blot. Emx2 is no longer expressed in neurons (normalized for 
actin).  
(C) Dissociated aggregates generate spindle shape progenitors 2 hr after 
plating. Note the larger size and branched process of mutant progenitors 
(arrow).  
(D) Immunostaining of ES cell-derived progenitors for mash1, emx2, RC2, 
and Glast. Equal percentages of RC2+ and Glast+ progenitors are 
generated by WT and mutant ES cells. WT progenitors only express 
emx2, while mutant progenitors express mostly both emx2 and mash1. 
More mutant progenitors express mash1 (56.8% ± 4.0) compared to WT 
(9.1% ± 4.7) (*p < 0.05).  
(E) Western blot reveals that mutant progenitors express higher levels of 
Mash1 compared to WT. Mash1 is not expressed in neurons (normalized 
for actin). 
(F) RT-RCR for Ngn2 and Tbr1 reveals that expression of both genes is 
dramatically decreased in mutant progenitors and neurons respectively, 
compared to WT.  
 
Scale bars: (A), 100 μm; (C), 50 μm (top row), 25 μm (bottom row); (D), 100 
μm (top rows), 50 μm (bottom rows). 
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Figure 7 
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Figure 7. Pax6 Specifies the Glutamatergic Phenotype of ES Cell-Derived 
Neurons 
 
(A) Staining of WT and mutant ES cell-derived neurons after 4 days in vitro 
for vGLUT1 and Tuj1. Most WT neurons express vGLUT1, but mutant 
neurons do not.  
 
(B) Six-day-old ES cell-derived neurons co-stained for vGAT, neurofilament, 
and a nuclear dye (top row), and for GAD or Calretinin.  
 
 
(C–E) Quantification of the number of cells expressing vGAT (C), GAD (D) 
and 
      calretinin (E) reveals that almost all mutant neurons express these 
markers, 
       while the majority of WT neurons do not (*p < 0.05, **p < 0.01).  
 
(F) Western blot also indicates that mutant neurons express higher levels of 
       vGAT and Calretinin compared to WT (normalized for actin).  
 
(G and H) Neurons derived from mutant ES cells infected with a GFP or 
Pax6- 
      IRES-GFP retroviral vector were co-cultured in a 1:1 ratio with WT 
neurons 
      and co-stained with antibodies against vGAT and GFP (G), or for vGLUT1 
(H). 
      The majority of GFP+ mutant neurons express vGAT (G), while neurons 
      expressing Pax6 do not express vGAT, but express vGLUT1 (G and H).  
      Significantly fewer neurons expressing Pax6 are vGAT+ (16.3% ± 4.36) 
      as compared to neurons expressing GFP only (73.4% ± 4.76) (*p < 0.01). 
(H)  
     The percentage of mutant neurons infected with Pax6-IRES-GFP 
expressing 
      vGLUT1 was quantified based on the total number of GFP+ cells.  
 
Scale bars: (A) 100 μm (top row), 50 μm (bottom two rows); (F) 50μm. 
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Figure 8. Differentiation Potential of ES Cells and of WT and Mutant ES 
Cell-Derived Progenitors in the Chick Telencephalon 
 
(A) Schematic of the chick embryo (10–12 somite stage) with a lesion in the 
prospective dorsal (red) or ventral (blue) telencephalon.  
 
(B–F) The diagrams indicate where the lesion was made and the aggregate 
placed (red area). The blue box indicates where the picture was taken. All 
experiments were immunostained for vGLUT1 and vGAT.  
 
(B) RA treated WT (mapt::GFP) aggregates implanted in the prospective dorsal 
telencephalon. Most GFP+ cells express vGLUT1 (n = 4) and are incorporated 
into the cortex.  
 
(C) RA treated WT (mapt::GFP) aggregates implanted in the prospective ventral 
telencephalon. Most GFP+ cells express vGLUT1 (n = 4) and fail to migrate to 
the cortex.  
 
(D) RA untreated (naive) WT (mapt::GFP) aggregates implanted in the 
prospective ventral telencephalon. Many GFP+ cells express vGAT (n = 4), 
populate the ventral telencephalon, and migrate to the cortex.  
 
(E) RA-treated mutant (mapt::GFP) aggregates implanted in the prospective 
ventral telencephalon. The vast majority of GFP+ cells express vGAT (n = 4) and 
migrate to the cortex.  
 
(F) RA-treated mutant (mapt::GFP) aggregates implanted in the prospective 
dorsal cortex. Mutant cells do not integrate well in the cortex, but exhibit a 
clustering behavior. Most express p75NTR at high levels (Figure S1). The 
percentage of GFP-positive cells expressing vGLUT1 or vGAT was quantified (n 
= 4). 
      
      Scale bars: (B)–(F), 100 μm (top rows), 50 μm (bottom rows). 
 53
 
Figure 9
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Figure 9. Mutant Neurons Exhibit Aberrant Expression of p75NTR and TrkB 
and Die Prematurely 
(A) Staining of WT and mutant ES cell-derived neurons for Tuj1 and a nuclear 
dye. After 4 days in vitro, mutant neurons exhibit shorter and thinner processes 
compared with WT neurons and die prematurely after 8 days.  
(B) Cell death in WT and mutant neuronal cultures from day 1 to day 8 in vitro as 
the percentage of neurons exhibiting a pyknotic nuclear morphology. Most 
mutant neurons die between day 7 and 8 in vitro (*p < 0.05, **p < 0.01).  
(C) Mutant ES cell-derived neurons fail to upregulate TrkB and express higher 
levels of p75NTR, as shown by western blot.  
(D) Neurons derived from mutant ES cells infected with a retroviral vector 
expressing either GFP alone or Pax6-IRES-GFP were co-stained for Tuj1 and 
GFP. Infected neurons were co-cultured with WT ES cell-derived neurons. While 
mutant neurons expressing GFP alone fail to survive longer than 8 days, mutant 
neurons expressing Pax6 survive for at least 13 days and develop a complex 
morphology with branching and filopodia (arrow).  
(E) The survival of mutant neurons infected with Pax6-IRES-GFP or GFP alone 
was quantified after 8 days in vitro (*p < 0.01).  
Scale bars, 50 μm in all panels. 
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Figure 10
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Figure 10. Neurotrophin Receptor Expression and Cell Death in the Pax6 
Mutant Cortex 
(A) Immunostaining of E12 and E14 WT and Pax6 mutant (Sey/Sey) brains for 
p75NTR, TrkB, and neurofilament. The mutant cortex exhibits ectopic 
overexpression of p75NTR at E12 and lacks TrkB protein both at E12 and E14.  
(B) The mutant cortex contains more apoptotic cells at E12, as revealed by 
TUNEL, active caspase 3, and nuclear staining of cortical sections. These 
defects are less prominent at E14.  
(C) The E12 mutant cortex contains significantly more apoptotic cells (78.7% ± 
7.4) compared with WT (29.9% ± 5.8) (*p < 0.01).  
(D) Ectopic overexpression of p75NTR and increased numbers of caspase3 
positive cells are observed only in the cortex and in the olfactory bulb-like 
structure (arrows) of the mutant, but not in the ventral telencephalon (vTel).  
 
Scale bars: (A), 100 mm (first, third, and fourth columns); 200 μm (second   
column); (B), 50 μm; (D), 200 μm. 
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Figure 11
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Figure 11.  Increased Numbers of Transient GABAergic Cells in the Pax6 
Mutant Cortex at E12 
(A) Immunostaining of E12 WT and mutant cortex for vGAT, GAD, and calretinin. 
(B) Quantification revealed increased numbers of vGAT-, GAD-, and calretinin-
positive cells in the mutant cortex compared to WT.  
(C) Co-staining of E12 mutant cortex for vGAT and active caspase3 or p75NTR. 
Note that a large number of vGAT-positive and that these cells also express 
p75NTR and active caspase3. Nuclear staining revealed a pyknotic nuclear 
morphology of cells in the cortical plate.  
(D) Immunostaining of E12 and E14 WT and mutant cortex for doublecortin and a 
nuclear dye.  
(E) Significantly more doublecortin-positive cells are present in the mutant cortex 
at E12 (*p < 0.05), but significantly fewer at E14 (*p < 0.01) as compared to WT.  
Scale bars: (A), 100 μm; (C), 50 μm; (D), 400 μm (top row), 100 μm (bottom row) 
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Figure 12 
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Figure 12.  Downregulation of p75NTR Prevents the Death of Pax6-Deficient 
Neurons 
(A) Neurons derived from mutant ES cells stably expressing a shRNA construct 
against p75NTR (3 different constructs) downregulate p75NTR after 2 days in 
vitro as shown by western blot analysis. Stable expression of a scrambled 
construct in mutant ES cells does not cause a downregulation of p75NTR in 
neurons.  
(B) Mutant neurons stably expressing shRNA constructs against p75NTR 
develop elaborate processes and survive, as shown by Neurofilament staining 
after 10 days in vitro.  
(C) Immunostaining of 10 day old mutant sh-p75 neurons for Neurofilament, 
vGAT, and Synaptophysin (Syn). Mutant sh-p75 neurons express vGAT in their 
cell bodies (arrow) and processes (arrowheads), and mature to form punctuate 
structures accumulating synaptophysin immunoreactivity.  
(D) Cortical sections of E12 WT (n = 3), Sey/Sey (n = 3) Sey/Sey;p75NTR+/- (n = 
3) and Sey/Sey;p75NTR-/- (n = 2) brains were stained for TUNEL. Fewer 
TUNEL+ (red arrows) cells are present in the Sey/Sey;p75NTR-/- cortex as 
compared to Sey/Sey;p75NTR+/-.  
(E) Increased number of GAD-positive neurons in the E14 Sey/Sey;p75NTR-/- 
cortex, as compared to WT or Sey/Sey;p75NTR+/-. Arrow indicates GAD-positive 
neurons in the subventricular zone and arrowheads in the marginal zone.  
Scale bars: (B), 100 μm; (C), 50 μm; and (D) and (E), 100 μm. 
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                     Figure 13
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Figure 13.  Expression of p75 in mutant ES-derived neurons following 
transplantation in the developing chick telencephalon 
Sections were stained for GFP and p75 8 days after transplantation of mutant, 
RA-treated aggregates into the prospective ventral or dorsal telencephalon. The 
schemes indicate the implantation sites of the aggregates (red area) and the 
sites where the pictures were taken (blue box). Most mutant ES-derived neurons 
downregulate p75 expression when implanted in the ventral, but not in the dorsal 
telencephalon.
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2.2) THE ROLE OF NEUROTROPHIN TYROSINE KINASE (TRK) 
RECEPTORS IN DEVELOPING NEURONS  
Tyrosine kinase receptors of the Trk family expressed by growing axons bind 
neurotrophins selectively, resulting in the activation of their kinase domain (for 
review see Bibel and Barde, 2000).  This process is well recognized to account 
for the ability of target-derived neurotrophins to regulate the survival of large 
numbers of neurons in the peripheral nervous system, during the period of 
naturally occurring cell death.   Why PNS neurons become exquisitely dependent 
on neurotrophins for survival has remained a mystery. In addition, this feature is 
not shared by most CNS neurons. While CNS neurons respond to neurotrophins 
by regulating neurotransmitter release and synaptic function, neurotrophin 
signaling is dispensable for their survival. Virtually all CNS neurons express TrkB 
at relatively high levels, compared with TrkA and TrkC (see suppl. Fig.20), and 
yet in the absence of the TrkB ligands BDNF and NT4, the survival of most CNS 
neurons is not affected. Hitherto, comparing the activity of the 3 Trk receptors in 
the absence of ligand, when they are not activated, in one and the same 
neuronal context has been virtually impossible as acute cell transfection typically 
leads to receptor auto-activation and uneven number of receptors. In the second 
part of my thesis, I used the neuronal differentiation of ES cells in order to 
circumvent this difficulty and compared the instructive functions of the 3 Trk 
receptors in an identical neuronal context.   
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2.2.1) TrkA and TrkC trigger neuronal death, TrkB does not 
The neuron-specific mapt (tau) locus was targeted in ES cells (Plachta et al., 
2007) with cDNAs encoding TrkA, TrkB or TrkC with or without an additional 30 
nucleotide sequence corresponding to a hemagglutinin (HA) epitope (Bibel et al., 
1999). These ES cells were subjected to a differentiation protocol resulting in the 
generation of virtually pure progenitors expressing Pax6, a transcription factor 
instructing them to synchronously differentiate into glutamatergic neurons (Bibel 
et al., 2004; Nikoletopoulou et al., 2007).  Previous experiments have shown that 
the mapt locus begins to be expressed soon after the progenitors exit the cell 
cycle4 and quantification of TrkA, TrkB and TrkC receptors using HA antibodies 
indicated indistinguishable levels of expression already 3 days after plating the 
progenitors (days in vitro, div, Fig. 14A, B). This strategy allows a precocious, but 
moderate expression of Trk receptors, as endogenous TrkB is expressed at 
significant levels only later (Fig. 14C). By 7 div, the endogenous levels of TrkB 
are clearly higher than those observed at 3 div when Trk receptor expression is 
under the control of the mapt promoter (Fig. 14C). TrkB and p75 are the only 
neurotrophin receptors detected with antibodies in this ES cell-based 
differentiation system (Bibel et al., 2004). We observed that neurons expressing 
TrkA and TrkC, but not TrkB, all died between 4 and 6 div (Fig. 14D). Identical 
results were obtained with HA-tagged and unmodified Trk cDNAs (data not 
shown). As expected, neurons expressing TrkA or TrkC could be rescued by the 
addition of NGF or of NT3 respectively (Fig. 14D, E). The possibility that neurons 
expressing TrkB ahead of schedule may survive as a result of secretion of 
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endogenous BDNF was excluded by incubating neurons with a monoclonal 
antibody blocking the activity of BDNF (Fig. 14F). K252a, an inhibitor of Trk 
tyrosine phosphorylation, failed to cause the death of mapt::TrkB neurons (Fig. 
14F) or of wild-type neurons (data not shown). When used at identical 
concentrations, K252a completely blocked the rescue activity of NGF and NT3 
observed with mapt::TrkA and mapt::TrkC neurons (Fig. 14G, H). K252a alone 
failed to prevent the death-inducing activity of TrkA or of TrkC. Targeting the 
second mapt allele with GFP did not cause any measurable changes compared 
with wild-type mapt alleles or with one allele targeted with HA-tagged or 
unmodified TrkB cDNAs. 
2.2.2) Mapt::TrkA and Mapt::TrkC embryos lose their nervous system  
Large scale death of the developing nervous system has been reported to be 
incompatible with the development of viable embryos, therefore preventing the 
generation of animals capable of germ line transmission (Gao et al., 1998). To 
test the relevance and generality of our in vitro findings in the context of the 
developing nervous system, we used an alternative approach based on tetraploid 
complementation allowing the generation of mouse embryos entirely derived 
from ES cells (Nagy et al., 1993). To this end we used ES cells expressing GFP, 
TrkA, TrkB, or TrkC from one of the 2 mapt alleles. GFP expressed from the 
second mapt allele was used to facilitate the visualization of phenotypes during 
neurogenesis. As previously reported, this strategy allows an early and 
comprehensive visualization of the developing central and peripheral nervous 
system (Tucker et al., 2001). When examined at E11.5, no obvious differences 
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were observed between any of the 4 genotypes examined, indicating that the 
initial steps of neurogenesis remain largely unaffected. In particular, peripheral 
ganglia could readily be observed in all 4 cases (Fig. 15A). However, 2 days 
later, while embryos expressing GFP or TrkB still appeared normal, TrkA and 
TrkC-expressing embryos exhibited a widespread and massive loss of the GFP 
signal (Fig. 15A). Cross-sections stained with antibodies against β-III tubulin 
revealed that most neurons were eliminated at E13.5 in both TrkA- and TrkC-
expressing embryos (Fig. 15B). In spite of the lack of gross morphological 
effects, quantification of caspase-3 activity at E11.5 revealed a significant 
increase in the number of apoptotic neurons in TrkA and TrkC embryos 
compared with either TrkB-expressing or control embryos (Fig. 15C). These 
findings indicate that the death-inducing function of TrkA and TrkC has the 
potential to operate in all developing neurons, regardless of their identity, location 
and developmental history. Increased levels of developmental cell death 
observed in the dorsal root ganglia (DRG) of TrkA and TrkC embryos suggest 
that higher than normal levels of TrkA and TrkC are sufficient to cause the death 
of sensory neurons. However, unlike in the CNS, some sensory neurons do 
escape cell death (Fig. 15B, arrows), presumably when their axons come in 
contact with sufficient quantities of the corresponding neurotrophin. 
2.2.3) TrkA- and TrkC-induced death requires p75 cleavage 
Neurons generated in our ES cell-based differentiation system express the 
neurotrophin receptor p75 at significant levels and moderate p75 over-expression 
has previously been shown to cause their rapid death (Plachta et al. 2007; 
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Nikoletopoulou et al. 2007). As there is evidence that Trk receptors interact with 
p75 (Bibel et al. 1999), we then tested the possibility that p75 may be involved in 
the death caused by TrkA and TrkC. We found that cell death is decreased in 
neurons derived from mapt::TrkA ES lines stably expressing shRNA against p75 
(Nikoletopoulou et al. 2007), compared to lines expressing scrambled shRNA 
sequences (Fig. 16 A,B). An involvement of p75 in the death phenotype 
observed with the mapt::TrkA and mapt::TrkC neurons is also suggested by the 
visualization by Western blots of p75-related peptides corresponding to the C-
terminal fragment (CTF) and intra cellular domain (ICD) of p75 (Fig. 16C). These 
proteolytic products were not observed in the lysates of mapt::TrkB (Fig. 16 C,D). 
Previous work with p75 revealed that CTF and ICD are generated by the 
sequential activity of membrane-bound proteases (Jung et al., 2003; Kanning et 
al., 2003; Weskamp et al., 2004). A “sheddase” first cleaves off the extracellular 
domain of p75, leaving behind the membrane bound CTF further processed by 
the γ-secretase complex to release the death-inducing ICD (see below) (Frade, 
2005; Kenchappa et al., 2006). To begin to understand how this initial proteolytic 
event can be triggered in mapt::TrkA and mapt::TrkC cells soon after the initiation 
of neuronal differentiation, we examined the corresponding lysates with 
antibodies to activated protein kinase C (PKC). Indeed, previous work showed 
that the proteolysis of a variety of membrane-bound proteins, including p75, is 
initiated by PKC-mediated activation of “sheddases”13. Western blot analysis of 
TrkA- and TrkC-expressing neurons revealed increased levels of phosphorylated 
PKC (pPKC) already after 2 div, which was largely prevented by the addition of 
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NGF (Fig. 16E) or of NT3 (data not shown). pPKC levels were not increased in 
TrkB-expressing neurons. To test the causal involvement of PKC activation in 
TrkA and TrkC-induced death, we then incubated the neurons with the PKC 
inhibitor Go6983 and found that it delayed neuronal death (Fig. 16F). As PKC 
activation and extracellular cleavage of p75 was previously shown to be a 
prelude to further cleavage of p75 leading to ICD release and cell death 
(Weskamp et al., 2004), we then tested the inhibitor LY411575, one of the most 
potent inhibitors of γ-secretase activity (Abramowski et al., 2008). Treatment of 
mapt::TrkA and mapt::TrkC neurons with LY411575 abolished the generation of 
p75 ICD fragment, as did incubation with the corresponding neurotrophin (Fig. 
16G). LY411575 also prevented the death induced by TrkA and TrkC, to an 
extent similar with that observed following incubation with NGF or NT3 (Fig. 
16H). 
2.2.4) Sensory neurons death is prevented by inhibition of γ-secretase 
TrkA activation by NGF in sympathetic and sensory neurons is well known to be 
required in order to prevent cell death during development (Smeyne et al., 1994). 
In view of the death-inducing role of TrkA in the absence of NGF and the 
proteolytic cascade TrkA rapidly initiates we then examined the response of chick 
dorsal root ganglia (DRG) cultured in the presence of the γ-secretase inhibitor 
LY411575 and in the absence of NGF. At 8 days of development, the majority of 
DRG neurons expresses both TrkA and p75 and depends on NGF for survival. 
NGF is also well known to cause massive axonal elongation in DRG explants 
(Levi-Montalcini et al., 1954).  We found that LY411575 significantly increased 
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the survival of DRG neurons and that it caused substantial axonal outgrowth from 
DRG explants (Fig.17 A,B). This result is also consistent with previous findings 
indicating that down-regulation of Trk receptors in transgenic animals with a 
precocious expression of the transcription factor EWS-Pea3 in sensory neurons 
leads to neurotrophin-independent survival and axonal outgrowth (Hippenmeyer 
et al., 2005). As the finding that TrkA expression causes cell death suggests that 
it is causally involved in the dependency on NGF for survival in vivo, we then 
quantified the levels of programmed cell death in lumbar DRGs in mice lacking 
TrkA (Moqrich et al., 2004). While ngf-/- mutants already exhibit a 7-fold increase 
in the number of apoptotic neurons at E 11.5, the levels of cell death in TrkA 
mutants was not significantly different compared to wild-type animals (Fig.18 
A,B). As previous reports indicate that trkA-/- neurons die at later time points 
(White et al. 1996) and because TrkA neurons are known to express high levels 
of p75, we then tested if the expression of p75 in the absence of TrkA may be 
sufficient to explain delayed cell death in the DRG, as previously observed with 
sympathetic neurons (Majdan et al., 2001). We found that at E14.5, mice lacking 
both TrkA and p75 (von Schack et al., 2001) display significantly less cell death 
in their lumbar DRG compared with single trkA mutant animals (Fig.18 C,D). 
Neurons of the superior cervical ganglia (SCG) constitute a population well 
known to express TrkA and to depend on NGF for its survival.  We then 
compared the survival of SCG neurons isolated from E17 wildtype and trkA 
mutant embryos and cultured in the presence or absence of NGF (Fig.18 E).  We 
found that trkA mutant neuronal cell bodies readily survive the absence of NGF 
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(Fig.18 E, arrows) but that they only extend short processes.  By contrast, 
virtually all wildtype neurons die within 24 hours in the absence of NGF.  In 
addition, while wildtype neurons respond to NGF by surviving and extending 
elaborate processes, TrkA mutants die rapidly in the presence of NGF, 
presumably because NGF activates p75 leading to apoptosis.  In line with this, 
preliminary results indicate that SCG neurons lacking both TrkA and p75 
receptors are able to survive in the presence as well as in the absence of NGF 
(data not shown). In addition, they do extend processes, presumably because of 
the known inhibitory activity of p75 in process elongation by modulation of RhoA 
activity (Yamashita et al., 1999).    
2.2.5) TrkA, TrkC, not TrkB, in p75-, flotillin-rich fractions 
As the 2-step proteolysis of p75 is reminiscent of the processing of amyloid 
precursor protein in cholesterol-rich domain, often referred to as lipid rafts 
(Cheng et al., 2009; Vetrivel et al., 2005), we then fractionated detergent-
resistant membranes of 4 div ES-derived neurons and monitored cholesterol 
enriched fraction with flotillin-1 as surrogate marker (Bronfman, 2007). Western 
blot analyses revealed that 90.3% of TrkA and 94.5% of TrkC protein localized in 
flotillin-1-rich fractions. By contrast, most of TrkB was found in the pellet devoid 
of flotillin-1. Similarly, flotillin-1-rich fractions contained 92.7% of p75 in TrkA- and 
73.2% in TrkC-expressing neurons, whereas in TrkB expressing neurons only 
34.1% of p75 was in these fractions. Control neurons expressing GFP from the 
mapt locus exhibited an intermediate segregation of p75, with 67.4% in the upper 
fractions and 32.4% in the pellet (Fig.19). 
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Figure 14
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Figure 14.  TrkA and TrkC, but not TrkB, cause neuronal death in ES cell-
derived neurons 
 
(A) Trk protein levels in mapt::TrkA, mapt::TrkB or mapt::TrkC neurons (3 div). 
Staining is with a monoclonal antibody against the HA epitope.  
 
(B) Quantification of HA expression (N=2, mean ± SEM, t-test).  
 
(C) Trk expression from the mapt locus (left) or from the endogenous promoter 
(right). Western blot is with a panTrk antibody.  
 
(D) β-III tubulin staining of control and Trk-expressing neurons cultured without 
(top) or with the indicated neurotrophins (bottom). Control, mapt::TrkB and 
mapt::TrkC cultures (6 div), mapt::TrkA (4 div).  
 
(E) Percentage of active caspase-3 positive neurons (N=7, mean ± SEM, t-test. P 
values shown on black bars refer to comparison with wild-type. t-test between 
NGF or NT3 treatments and the corresponding non-treated cells, P<0.0001).  
 
(F) β-III tubulin staining of mapt::TrkB neurons (8 div) treated at 2 div with either 
K252a or with a monoclonal antibody blocking BDNF activity.  
 
(G) β-III tubulin staining of mapt::TrkA and mapt::TrkC neurons cultured with or 
without neurotrophin, K252a or both.  
 
(H) Percentage of active caspase-3 positive mapt::TrkA and mapt::TrkC neurons 
treated with neurotrophins, K252a or both (N=9, mean ± SEM, t-test. P values 
refer to comparison with untreated samples).  
 
Scale bars: 100 μm.
 74
Figure 15 
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Figure 15.  Embryos generated from TrkA, TrkB, TrkC or GFP expressing 
ES cells 
 
(A) Visualization of the nervous system by GFP expressed from the endogenous 
mapt locus.  
 
(B) β-III tubulin staining in transverse sections at day 11.5 and 13.5 of embryonic 
development (E11.5 and E13.5). Note the loss of GFP signal in TrkA and TrkC 
embryos between E11.5 and E13.5.  
 
(C) Quantification of active caspase-3 positive neurons in the spinal cord (SC) 
and dorsal root ganglia (DRG) at E11.5 (N=3, mean ± SEM, t-test, P values refer 
to comparison with mapt::GFP).  
 
Scale bars: panel B,100μm
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Figure 16 
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Figure 16.  Proteolysis of p75 mediates the death of mapt::TrkA and 
mapt::TrkC ES cell-derived neurons 
 
(A)  β-III tubulin staining of mapt::TrkA neurons stably expressing a scrambled 
shRNA sequence, or a shRNA against p75 (5 div).  
 
(B) Percentage of apoptotic neurons (Hoechst staining) after 5 div (N=7, mean ± 
SEM, t-test,). 
  
(C) p75 expression in lactacystin-treated control, mapt::TrkA, mapt::TrkB and 
mapt::TrkC (lysates at 3 div).  
 
(D) Quantification of CTF and ICD as a percentage of full length p75 using Image 
J software (mean ± SEM, N=2, t-test).  
 
(E) Detection of phosphorylated PKCα/βII in mapt::TrkA and mapt::TrkB neurons 
(2 and 4 div).  
 
(F) β-III tubulin staining of mapt::TrkA neurons untreated or treated with Go6983 
(2 div) and percentage of active caspase-3 positive mapt::TrkA and mapt::TrkC 
neurons treated with Go6983 or untreated (N=7, mean ± SEM, t-test). 
  
(G) p75 expression in lactacystin-treated mapt::TrkA and mapt::TrkC neurons. H. 
β-III tubulin staining of mapt::TrkA and mapt::TrkC neurons treated with NGF and 
NT3 respectively or with LY411575 (8 div).  
 
Scale bars: panels A and E, 50 μm; panel G,100μm.
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Figure 17 
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Figure 17.  γ-secretase-dependent proteolysis is involved in the death of 
sensory neurons.  
 
(A) Neurofilament staining of dissociated (top row) or whole (bottom row) dorsal 
root ganglia isolated from E8 chick embryos cultured with or without NGF or 
LY411575.  
 
(B) Quantification of 3 div apoptotic neurons (two-tail t-test, N=18 per condition). 
 
Scale bars: 100μm.
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Figure 18
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Figure 18.  Analysis of sensory neuron death in ngf, trkA and trkA/p75 
mutant embryos 
 
(A) Active caspase-3 staining of spinal cord and lumbar dorsal root ganglia 
(DRG) sections. 
  
(B) Number of active caspase-3 positive DRG neurons in E11.5 embryos of the 
indicated genotypes (t-test, N=4 embryos per genotype). 
  
(C) Active caspase-3 staining of spinal cord and lumbar DRG cross sections. 
  
(D) Number of active caspase-3 positive DRG neurons in E14.5 embryos of the 
indicated genotypes (t-test, N=3 embryos per genotype).  
 
Scale bars: 100 μm.
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Figure 19 
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Figure 19.  Segregation of p75 and Trk receptors in flotillin-rich factions 
 
Western blot with antibodies to HA, p75 and flotillin-1 in detergent-resistant 
following fractionation of neuronal lysates by sucrose gradient. Lysates are from 
ES cell-derived neurons expressing TrkA, TrkB, TrkC or GFP from the mapt 
locus. Quantification of HA and p75 bands is presented as a percentage of total 
expression in the upper fractions plus the pellet. 
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Figure 20.  Trk receptor expression in the developing nervous system.  
 
In situ hybridizations with probes against TrkA, TrkB or TrkC are from the Allen 
Brain Atlas.
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3. DISCUSSION 
In my thesis, I provided two examples of using genetically modified ES cells as a 
tool in neurobiology.  First, I will discuss the results obtained with ES cells 
carrying a mutation in the Pax6 gene, and then the ones obtained with ES cells 
engineered to expressed the 3 Trk receptors under the endogenous mapt 
promoter.    
3.1) THE ROLE OF PAX6 IN CORTICAL NEUROGENESIS 
3.1.1) ES cells as a tool to study the specification of neural progenitors 
during development  
The discovery that uniform populations of Pax6-positive RG cells can be 
generated from mouse ES cells makes it now possible to study early 
developmental events that have been previously very difficult to access in the 
mammalian CNS. As ES cell-derived progenitors become glutamatergic neurons 
in vitro when cultured under minimal conditions, we interpret these results to 
mean that Pax6-positive progenitors are intrinsically committed to become 
glutamatergic neurons, and that under permissive conditions in vitro, they follow 
the differentiation pathway adopted by their in vivo counterparts (Malatesta et al., 
2003). In the present study, we tested if ES cell-derived progenitors are also 
committed to become glutamatergic neurons after implantation in the developing 
chick telencephalon. Following implantation in the prospective dorsal 
telencephalon, we found large numbers of vGLUT1- positive neurons in the 
developing cortical plate of the chick (Figure 8B). The commitment of these cells 
to become glutamatergic neurons was revealed by their implantation in the 
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prospective ventral telencephalon, as most cells failed to become GABA-ergic 
neurons as they normally should in this location or else after migration in the 
dorsal telencephalon. They instead adopted a glutamatergic phenotype and 
failed to migrate to the cortex (Figure 8C). The critical control experiment with 
RA-untreated, naive ES cells also implanted in the prospective ventral 
telencephalon revealed large numbers of mouse cells in the chick cortex that 
were positive for the vGAT (Figure 8D). These results are in line with the view 
that most cortical GABA-ergic neurons originate from the ventral telencephalon 
(Cobos et al., 2001) and indicate that pluripotent mouse ES cells can be 
instructed by the host cues to become GABA-ergic neurons and to adopt a 
migratory phenotype. The results obtained following transplantation of WT 
progenitors prompted us to examine the behavior of mutant progenitors. We 
found that when transplanted in the ventral telencephalon, they uniformly 
generated GABAergic neurons that successfully migrated in large numbers and 
colonized the chick cortex (Figure 8E). These findings indicate that the 
neurogenic potential of Pax6 mutant progenitors is not compromised, and that 
they can generate GABA-ergic neurons that survive and adopt a migratory 
behavior similar to that of the endogenous interneurons. However, implanting the 
progenitors derived from Pax6 mutant ES cells in the prospective dorsal chick 
telencephalon led to the generation of only small numbers of neurons that were 
GABA-ergic but failed to integrate, aggregated, and died (see Figure 8F). While 
these results confirmed the view that progenitors derived from Pax6 mutant ES 
cells are committed to become GABAergic neurons, they also raise the question 
 88
of why the survival of neurons derived from mutant progenitors differs depending 
on where they are implanted in the chick embryo. All we know at this point is that, 
unlike in vitro, some ES cell-derived progenitors do survive after transplantation 
and that this is accompanied by a downregulation of p75NTR expression (Figure 
13). 
3.1.2) Mechanisms of neural progenitor misspecification 
While the progenitors generated from ES cells lacking Pax6 were found to 
express the transcription factor Emx2, they expressed the bHLH factor Mash1 
that characterizes ventral telencephalic progenitors and lacked expression of 
neurogenin2 that characterizes cortical (Fode et al., 2000) and WT ES derived 
progenitors. This result fits well with previous observations on the cortex of the 
Pax6 mutants showing that the Mash1-positive domain extends to the dorsal 
pallium (Stoykova et al., 2000; Toresson et al., 2000; Yun et al., 2001), while 
neurogenin2 expression is drastically reduced (Scardigli et al., 2003). 
Reintroduction of Pax6 in mutant ES cells with a retrovirus indicated that Pax6 
cell autonomously prevents the expression of ventral genes in the progenitors, 
thereby specifying a glutamatergic lineage and suppressing a GABA-ergic 
phenotype. In addition to the ventralization of the pallium, it has long been 
recognized that the cortex of mammals lacking Pax6 is grossly abnormal 
(Schmahl et al., 1993), including in particular the loss of almost half the number 
of neurons (Heins et al., 2002). Though we expected Pax6 to be required for the 
generation of RG cells and neurons (Heins et al., 2002), we found that mutant ES 
cells generate neurogenic RG cells as efficiently as WT ES cells. These 
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experiments thus indicate that Pax6 cell autonomously specifies the ES cell-
derived RG cells to generate glutamatergic neurons and that, in its absence, 
Mash-1 is upregulated, and that their progeny has the characteristics of 
GABAergic neurons. 
3.1.3) Mechanisms of neuronal elimination in the developing cortex 
In light of the premature death of the mutant ES cell derived neurons, we 
reexamined the question of neuronal death in the Pax6 mutant (Sey/Sey) cortex 
as none of the previous studies (Quinn et al., 2007; Warren et al., 1999) retained 
cell death as an explanation for the neuronal losses in the Pax6 mutant cortex. At 
E12, i.e., earlier stages than in most previous studies, we readily found cohorts of 
apoptotic GABA-ergic neurons. In cultures, the GABAergic neurons generated by 
mutant progenitors massively upregulate the neurotrophin receptor p75NTR, well 
known to cause cell death, and fail to express significant levels of TrkB, the 
‘‘trophic’’ receptor progressively upregulated in WT progenitors during the course 
of their neuronal differentiation (Bibel et al., 2004). In line with the possibility of 
imbalance between the levels of expression of p75NTRand TrkB in mutant cells, 
we found that three different mutant lines expressing shRNA targeting p75NTR 
survived like WT cells. These results further showed that the loss of TrkB is not 
per se the cause of the death of these neurons, as suppression of p75NTR was 
sufficient to significantly decrease neuronal death both in vitro and in vivo in line 
with previous observations indicating that TrkB null mutants do not exhibit 
significant levels of cell death in the developing cortex (Silos-Santiago et al., 
1997). This result is also in agreement with previous studies indicating that 
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overexpression of p75NTR in neurons in vivo (Majdan et al., 1997) or in ES cell-
derived neurons (Plachta et al., 2007) is sufficient to cause neuronal death. 
p75NTR overexpression and cell death was found to mostly affect the population 
of GABAergic neurons that was inappropriately generated in the cortex, most 
likely as a result of premature exit from the cell cycle of misspecified cortical RG 
cells (see also (Kroll and O'Leary, 2005). As noted, there is an early wave of 
increased neurogenesis in the Pax6 mutant cortex (Quinn et al., 2007 and our 
own results with doublecortin staining), consistent with a 3-fold increase in the 
number of GAD- and vGAT-positive neurons in the mutant cortex at E12 as 
compared to WT (Figure 11). In a recent study, Pax6 was suggested not to have 
an early role in neuronal specification based on an in situ hybridization 
experiment indicating that GAD65 mRNA was not upregulated, but rather 
downregulated at E13.5 in the Pax6 mutant cortex, as compared to WT 
(Schuurmans et al., 2004). Our results indicate that the misspecified GABAergic 
neurons generated very early are also rapidly eliminated, suggesting that most 
have already died when the mutant cortex is examined at E13.5. In line with this, 
our own in situ hybridization experiments indicate that GAD65 is indeed 
expressed at E12 in the Pax6 mutant cortex (data not shown). These results are 
reminiscent of those recently obtained in the retina, where Pax6 was proposed to 
play a very early role in the specification of retinal neurons. Like in the developing 
cortex, in the absence of Pax6, misspecified retinal neurons differentiate 
prematurely and die (Philips et al., 2005). 
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3.2) BIOLOGICAL FUNCTIONS OF TRK RECEPTORS DURING 
DEVELOPMENT 
3.2.1) Physiological role of death inducing activity of TrkA and TrkC during 
naturally occurring neuronal death 
Our findings indicate that TrkA and TrkC cause the death of newly born neurons 
throughout the developing nervous system in the absence of ligand-mediated 
activation. By contrast, TrkB fails to do so.  As TrkB is expressed in the CNS at 
far higher levels and more widely compared with TrkA and TrkC (Figure 20), our 
observations invite the speculation that cell numbers in the PNS are regulated by 
mechanisms that differ from those operating in the CNS, where cell contact-
based mechanisms appear more likely to regulate normally occurring cell death 
than those based on soluble growth factors.  The appealing view that neuronal 
numbers and innervation density are regulated by target tissues releasing limiting 
amounts of trophic molecules (Barde, 1989; Davies, 1988; Oppenheim, 1991; 
Purves, 1988) is based on observations made in the PNS, where there is ample 
evidence that elimination of any of the neurotrophin signaling component results 
in massive neuronal losses in the developing sensory and sympathetic ganglia 
(Crowley et al., 1994; Ernfors et al., 1994; Farinas et al., 1994; Klein et al., 1994; 
Klein et al., 1993; Minichiello et al., 1995; Pinon et al., 1996; Smeyne et al., 
1994).  Elimination of other growth factors such as glia cell line-derived 
neurotrophic factor (GDNF) and its receptors similarly leads to the loss of the 
enteric nervous system (Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 
1996; Schuchardt et al., 1994).   By contrast, the elimination of growth factors or 
of their receptors in the CNS fails to cause such dramatic cell losses during 
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normal development (Jones et al., 1994; Silos-Santiago et al., 1997), in the 
absence of lesion. 
Obviously, the lack of death-inducing activity of TrkB does not imply that its 
activation is not required to prevent neuronal death during development of PNS 
neurons. For example, the lack of BDNF causes the substantial loss of cranial 
sensory neurons and these neurons are known to require TrkB activation to 
survive (Ernfors et al., 1994; Jones et al., 1994; Silos-Santiago et al., 1997). 
However, mechanisms other than TrkB expression are most likely to predispose 
neurons to die, including high levels of expression of death-inducing receptors 
such as p75, NRH2 and TrkC (Ernfors et al., 1988; Murray et al., 2004; Stenqvist 
et al., 2005).  
3.2.2) Mechanisms of TrkA- and TrkC- induced death  
While our findings point to a key role of p75 as an effector of the death 
mechanisms initiated by TrkA and TrkC, it appears unlikely that p75 is the only 
molecule involved in this process.  The death of almost all neurons in the 
transgenic embryos expressing TrkA or TrkC suggests that related molecules are 
likely to play a role similar to p75.  Indeed, p75 is but one member of a large 
family of molecules, including the closely related NRH2 that can also associate 
with Trk receptors. NRH2 is expressed at high levels in several areas of the 
developing nervous system, including some where p75 is not detectable (Murray 
et al. 2004).   
As TrkA was identified as a receptor for NGF already in 1991 (Kaplan et al., 
1991; Klein et al., 1991) it may seem surprising that its death-inducing function 
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has not been previously reported.  However, Trk receptors readily auto-activate 
in the absence of ligand when expressed at high levels following acute 
transfection in cultured cells, and it is exceedingly difficult to control receptor 
expression in terms of timing, levels and evenness of expression unless 
endogenous promoters are used.   Not only does the mapt promoter drive 
moderate and equal levels of expression of the 3 receptors tested, but also it 
ensures expression within hours after exit of the cell cycle and the onset of 
neuronal differentiation.  It is typically at this time that neurons are eliminated in 
the developing nervous system during the process of naturally occurring cell 
death (Oppenheim, 1991) and our findings indicate that other key molecules 
such as p75 also need to be present at that time as effectors of the killing 
process. 
In line with our findings, a previous report indicated that acute over-expression of 
TrkC in HEK293 cells leads to increased levels of cell death in an activation-
independent manner (Tauszig-Delamasure et al., 2007).  Yet, this study failed to 
reach similar conclusions upon TrkA over-expression, presumably due to the 
limitations inherent to the use of un-controlled expression in non-neuronal tumor 
cells. 
Beyond new insights in nervous system development, our findings also help to 
better understand different prognoses associated with tumors of the nervous 
system, including neuroblastomas in particular. These tumors originate from 
neural crest derivatives and the long recognized better prognosis associated with 
tumors expressing TrkA or TrkC is now easier to rationalize (Lavoie et al., 2005; 
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Yamashiro et al., 1997).  By contrast, TrkB-expressing neuroblastomas are 
linked with poor prognosis (Eggert et al., 2000), in line with our finding that this 
receptor does not induce cell death when expressed in the very same cell in 
which TrkA and TrkC both  induce cell death. 
3.3) CONCLUSIONS AND PERSPECTIVES 
The findings of my PhD thesis suggest that ES cells represent a valuable tool to 
dissect relevant mechanisms operating during the development of the vertebrate 
nervous system.  The quality of the predictions obtained with this system could 
be verified both in the case of Pax6 and of the Trk receptors by the analyses of 
the corresponding mutant embryos.  How useful this differentiation system is can 
be illustrated by the fact that Pax6 and the Trk receptors have been reported 
about 20 years ago to be expressed in the developing mouse nervous system, 
and yet their role has remained very difficult to assess simply based on the 
analysis of the corresponding mouse mutants.  The analytical power of our ES 
cell-based system lies in the still incompletely understood fact that ES cell-
derived progenitors faithfully recapitulate in vitro early steps of corticogenesis.  In 
addition to published data from our laboratory (Bibel et al., 2007; Bibel et al., 
2004), we also profiled these cells in collaboration with the laboratory of 
Magdalena Goetz, which isolated endogenous cortical radial glial cells by 
fluorescence activated cell sorting at different developmental stages.  The 
comparative transcriptome of ES cell-derived and endogenous E12 neurogenic 
progenitors indicate that in spite of their different origins both types of progenitors 
are quite similar, while neurospheres or progenitors derived from ES cells by 
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different methods (Conti et al., 2005) show a transcriptome profile clustering 
more closely with what is seen with the E18 cortex, a time point when glia are 
generated in vivo.  Thus, as demonstrated with the transcription factor Pax6, this 
system can facilitate the study of genes controlling early aspects of 
neurogenesis, such as the generation, patterning, and developmental potential of 
cortical progenitors.    
In addition to the isolation of ES cells from existing mutants such as Pax6, 
another obvious, but particularly useful feature of ES cells is that they can be 
readily manipulated.  In particular, homologous recombination into a specific 
locus, such as mapt in my case, allows the control of both the levels and timing 
of expression of cDNAs.  As all progenitors and neurons are derived from a 
single ES clone, they carry identical genetic information.  This is in contrast to 
acute cDNA transfection often driven by ubiquitous promoters, resulting in 
uncontrolled over-expression in terms of numbers of copies and timing and cell 
type expressing the constructs.   
In addition, this system allows the effects of mutations or other genetic 
manipulations to be studied not only in an identical neuronal background, but 
also in cells that are essentially synchronous. As the progenitors undergo only 
one or two cell divisions before their terminal differentiation, neurons are born 
and mature together and therefore respond to the genetic manipulations they 
carry in a coordinated manner, making the identification of phenotypes easier.  
All these aspects were key to the observation that TrkA and TrkC, but not TrkB, 
kill developing neurons, perhaps the most surprising aspect of my work.  As ES 
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cell-derived neurons can be generated in essentially unlimited numbers, I could 
also generate sufficient numbers of neurons carrying TrkA, TrkB or TrkC to 
perform the necessary biochemical analyses.  In particular, the results presented 
in Fig.19 necessitated about 60 million neurons per condition.      
Since genetically modified ES cells can re-enter embryogenesis, even after being 
extensively expanded in vitro (see introduction), observations obtained with ES 
cell-derived progenitors and neurons can then be readily verified in vivo by the 
generation of mouse embryos.  With the tetraploid complementation assay as an 
alternative method to the classical generation of chimeras, the entire embryo is 
derived in one step from the ES cells of interest, making possible the generation 
of mutants with dominant lethal phenotypes.  An example was demonstrated in 
the second part of my thesis, with the generation of embryos expressing TrkA or 
TrkC under one mapt allele and which would have been impossible to obtain with 
other methods as they are embryonic lethal.     
Beyond the use of mouse ES cells as described in my work, it can be hoped that 
similar developments may take place with human ES cells. Given the isolation of 
human ES cell lines (Thomson and Marshall, 1998), it would appear in principle 
possible to address in the future questions related to neuronal specification and 
survival using human neural progenitors and neurons.  Such studies would 
greatly enhance our molecular and cellular understanding of how neural 
progenitor diversity is achieved in humans, including in particular why the human 
cortex is so much larger than that of the mouse. 
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However, the culture conditions necessary to maintain hES cells, and indeed 
even the identity of hES cells remain unclear at this point.  While mouse ES cells 
are typically propagated in the presence of LIF to maintain them pluripotent, hES 
cells are cultured instead by most laboratories in the presence of FGF, and it 
remains very unclear whether LIF signaling is necessary for the regulation of the 
key genes controlling pluripotency.  The difficulties with establishing satisfactory 
conditions for the propagation of pluripotent hES cells lines, are likely to arise 
from their identity and authenticity.   Recent work indicated that mouse 
pluripotent lines, defined as “epiblast stem cells” (epiSCs), isolated from embryos 
at later stages of development, require FGF instead of LIF to be maintained in 
culture (Tesar et al., 2007).  This observation invites the speculation that if 
signaling cascades operating at early stages of embryogenesis are conserved 
among mammals, the hES lines cultured by most laboratories may represent a 
mixture of authentic stem cells and of pluripotent epiSCs. As long as these basic 
problems have not been sorted out, it is unlikely that useful, robust neuronal 
differentiation protocols can be established with human ES cells.   
Re-programming of somatic cells offers yet another source of human pluripotent 
cells. This spectacular achievement takes its origin in early work, when Gurdon 
and his colleagues were successful in generating adult frogs after transferring 
nuclei isolated from intestine cells of the tadpole into enucleated unfertilized 
Xenopus laevis eggs (Gurdon, 1962a, b, c).  This finding demonstrated that the 
mature cell’s nucleus retains the capacity of re-activating genes necessary for 
pluripotency and is returned to a state from which it can go on to generate the 
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entire animal.  However, when the same experiment was performed with nuclei 
isolated from adult cells, they were able to generate tadpoles but not adult frogs, 
raising the concern that the more differentiated cells are the more limited their 
efficiency of being reversed. The next big step was by Wilmut and colleagues 
with the generation of the ewe “Dolly”, by fusing cultured mammary gland cells 
with enucleated eggs (Wilmut et al., 1997).  This stunning experiment, completed 
by the demonstration of germline transmission by the generation of several 
lambs that were born to Dolly, demonstrated beyond doubts that reprogramming 
from somatic cells can be very extensive in mammals.    
These experiments led to a search of re-programming factors that can directly 
convert differentiated cells into the pluripotent state, that culminated in 2006 with 
the report by Takahashi and Yamanaka that the epigenome of embryonic or adult 
differentiated cells can be erased by the introduction of initially 4 factors, Oct4, 
Sox2, Klf4 and c-Myc using viral vectors (Takahashi and Yamanaka, 2006).  The 
resulting induced pluripotent cells (iPS) do not seem to be substantially different 
from ES cells and 2 months ago several reports indicated that mice can be 
generated from such iPS cells (Boland et al., 2009; Zhao et al., 2009).  Even if 
work with human ES and iPS cells is not yet as far advanced as often assumed, 
it appears likely that not before long the impact of mutations affecting the human 
nervous system will be studied and much better understood using such 
strategies.  This type of work will be particularly important in cases where genes 
function differently or have no real equivalent in rodents (for a recent review see 
(Lengerke and Daley, 2009) 
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4. MATERIALS & METHODS 
Materials 
ES cell culture medium and ingredients were as described in details in 
Bibel et al., 2007. 
 
Pax6 mutant mouse ES Cells 
Mice heterozygous for the Pax6 gene (Sey/+) were crossed, and two 
independent homozygote Sey/Sey ES cell lines were isolated from the inner cell 
mass of pre-implantation blastocyst-stage embryos. WT and homozygote 
Sey/Sey mouse ES cells were differentiated as described in Bibel et al. (2004). 
To facilitate the detection of ES cell-derived neurons in chick embryos after 
transplantation, we used WT and (Sey/Sey) ES cells engineered to express 
green fluorescent protein (GFP) from both or one tau alleles, respectively (Bibel 
et al., 2004).  
 
Targeting of the mapt locus in ES cells 
Targeting of the endogenous mapt locus was performed as previously 
described7. A cassette containing the EGFP (Clontech, Palo Alto, California), 
TrkA, TrkB or TrkC cDNA, the Pgk-1 polyadenylation signal and the G418-
selectable marker Pgk-Neor was inserted between the PmeI and NotI sites of a 
plasmid containing exon 1 of the tau locus and 8.0 kb flanking genomic 
sequence. The linearized targeting vector was electroporated into J1 embryonic 
stem (ES) cells as described39 . 200 G418-resistant colonies were picked for 
each line and analyzed by Southern blot. The 5' external probe consisted of a 
500-base pair (bp) SmaI−EcoRI genomic fragment whose 5' end was located 2.8 
kb upstream of exon 1, and the 3' external probe consisted of a 600-bp 
BamHI−EcoRI genomic fragment whose 5' end was located 6.0 kb downstream 
of exon 1. 
 
RT-PCR  
Following RNA isolation and reverse transcription, Ngn2, Tbr1, and GADPH 
mRNA was amplified using the following primers: Ngn2, 
TCCAACTCCACGTCCCCATACCandGCTGCCAGTAGTCCACGTCTGA 
(primers corresponding to positions 658–678 bp and 709–730 bp, product size 
72 bp); Tbr1, GAGGCTCTGGAAACACGAAG and 
ACTCGACTCGCCTAGGAACA (primers corresponding to positions 3033–3053 
and 3192–3212, product size 160 bp); GADPH, TGAGGCCAGTGCTGAGTATG 
and CACATTGGGGGTAGGAACAC (product size 457 bp). 
 
Chick transplantations 
Fertilized White Leghorn eggs were incubated at 38.5oC with 80% humidity for 36 
hr (10–12 somites). Two ml of albumin was aspirated, and a small portion of the 
upper eggshell was discarded to access the embryo visualized with Pelikan ink 
(Pelikan drawing ink A) in phosphate- buffered saline (PBS) injected close to the 
blastoderm. The area of the prospective dorsal or ventral telencephalon was 
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removed with glass needles and filled with WT (tau::GFP) and Sey/Sey 
(tau::GFP) ES cell aggregates treated with RA for 4 days. Before implantation 
using tungsten needles, the aggregates were loosened by incubation in trypsin at 
37oC for 10 min. WT ES cell aggregates, not treated with RA, were similarly 
implanted. The eggs were then sealed and incubated a further 8–10 days. The 
embryos were then removed from the egg, fixed in 4% PFA for 24–48 hr at 4oC, 
incubated in 30% sucrose for 24–48 hr at 4_C, embedded in Tissue-Tech, and 
stored at -80oC until cryosectioning. 
 
Immunofluorescence 
Cells or tissue sections were rinsed in PBS and incubated for 1 hr in blocking 
solution containing 10% horse serum and 0.2% Triton in PBS. Sections were 
incubated with primary antibodies in blocking solution for 12 hr at 4oC. PBS was 
substituted for the primary antibodies to test for unspecific labeling. Sections 
were rinsed in PBS and incubated with the following secondary antibodies 
(molecular probes) for 1 hr at room temperature: anti-rabbit Alexa 488 or 594, 
anti-mouse Alexa 488 or 594, anti-mouse IGg1 Alexa 594, anti-goat alexa 594, 
and anti-guinea pig (1:1000, gift from S. Arber). The nuclear dye Hoechst 33342 
(10 mg/ml, Sigma) was used. Sections were rinsed in PBS and mounted. 
 
TUNEL Staining 
TUNEL staining on 12-mm-thick brain or spinal cord sections was performed as 
described by the manufacturer using the Roche In Situ Cell Death Detection Kit. 
 
In vivo quantifications of cell numbers in the chick telencephalon 
Cells transplanted in the chick telencephalon were stained with vGAT or vGLUT1 
antibodies (both are mouse specific) and the nuclear stain Hoechst. Cells with 
the highest density of puncta over the cell body around mouse nuclei were 
counted (7 independent transplantations per condition). Cells expressing vGAT, 
GAD, and Calretinin in the WT and mutant brain at E12 were counted similarly. 
Doublecortin-positive cells in WT and mutant cortices were counted with the 
‘‘Analysis’’ program. Quantifications were performed on 12-mm-thick sections. 
 
Western Blot 
Cells were lysed in 500 mM Tris-HCl pH 7.2, 1 M NaCl, EDTA, Triton 100-X, Na-
deoxycholate, 10% SDS, supplemented with protease inhibitors (Roche) and 1 
mM dithiothreitol (DTT), and placed for 20 min on ice, followed by 20 min 
centrifugation at 14,000 rpm. Samples were separated on a gradient (4%–12%) 
polyacrylamide gel (Invitrogen) and transferred to a polyvinylidene fluoride 
membrane (Immobilon- P, Millipore, IPVH00010). After blocking for 1 hr at room 
temperature in 5% skim milk, membranes were incubated in the primary 
antibodies overnight at 4_C. After three 5 min washes in TPBS 
(100mMNa2HPO4, 100mM NaH2PO4, 0.5N NaCl, 0.1% Tween-20), membranes 
were incubated for 1 hr at room temperature in secondary horseradish 
peroxidaseconjugated antibody (anti-mouse HRP and anti-rabbit HRP; Biorad). 
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Blots were developed by chemiluminescence (ECL, Amersham Pharmacia 
Biotech) according to the manufacturer’s instructions. 
 
Retroviral vectors and infections 
The Pax6-IRES-GFP viral vector contained the 2050 bp fragment with the entire 
coding region of Pax6 and parts of 50UTR and 30UTR inserted between the 
upstream LTR and the IRES sequence as described in Hack et al., 2004. Gpg 
helper-free packaging cells were used for viral production and resulted in titers of 
3 3 106 and 2.5 3 106 of Pax6-IRES-GFP or GFP viral particles, respectively. For 
the infections of mutant ES cells, we used 5 ml of virus per ml medium and 
infected the cells for 12 hr at 37_C, 5% CO2. Subsequently, they were washed 
three times with warm PBS and were processed for aggregate formation. 
 
Stable expression of shRNAs in ES cells 
Plasmids containing a neomycin resistance cassette were purchased from 
Genescript expressing three different shRNA constructs against p75NTR or a 
scrambled sequence under the H1 promoter and GFP under the CMV promoter. 
Plasmids were linearized, phenol-chloroform extracted, and twice precipitated 
with ethanol. Mutant ES cells (53106 cells)were resuspended in 600 ml 
electroporation buffer (137mM NaCl, 20 mM HEPES pH 7.0, 5 mM KCl, 0.7 mM 
Na2HPO4 pH 7.0, 6 mM dextrose, 0.1 mM b mercaptoethanol) and 
electroporated with 30 mg of linearized plasmid in 0.4 cm cuvettes (BIORAD) at 
400 volts and 25 mF. ES cells were subsequently plated on neomycin-resistant 
mouse embryonic fibroblasts. Two days after electroporation, 380 mg/ml G418 
was added to the medium for 10 days to select for neomycin- resistant clones. 
Individual GFP-positive clones were expanded to establish a line. 
 
Pax6 mutant animals 
Pax6Sey mice were maintained as heterozygotes on a mixed C57BL/ 6JxDBA/2J 
background. P75 exon IV mutant mice were maintained on a C57BL/6 
background and genotyped as described (von Schack et al., 2001). 
 
In vivo tetraploid complementation assay 
ES cell clones expressing TrkA, TrkB or TkC from one mapt allele and GFP from 
the second allele, or a control clone expressing GFP from both mapt alleles were 
aggregated with CD1 tetraploid embryos to generate ES cell-derived embryos as 
described11. Embryos were dissected at E11.5 and E13.5 and assessed for 
EGFP expression under fluorescence optics. 
 
Sub-cellular fractionation 
Neurons were homogenized in TNX buffer (25 mM Tris pH 7.5, 320 mM sucrose, 
150 mM NaCl, 1% Triton-X100), supplemented with a protease inhibitor cocktail 
(Roche). Samples were centrifuged; the supernatant was collected and 
centrifuged again. The pellet was re-suspended in TNX buffer and centrifuged. 
The pellet was sonicated and its sucrose content adjusted to 45%. Samples were 
transferred into 2ml open top ultra clear BECKMAN centrifuge tubes and overlaid 
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with 35% and 5% sucrose solutions. Samples were ultra-centrifuged. Fractions 
were collected from top to bottom and analyzed by Western blot . 
 
Chick DRG assay 
Whole DRGs were plated as explants on coverslips without neurotrophin, or 
supplemented with either NGF (50 ng/ml) or LY411575 (50 nM). DRG explants 
were cultured for 48 h, then fixed and stained. Alternatively, DRGs were 
trypsinized and plated as single cells on coverslips at a density of 5,000 neurons 
per well of a 12-well plate. After 48 hours, cells were fixed and immunostained. 
Antibodies and inhibitors 
The following antibodies were used: GAD (1:1000, Chemicon), Glast (1:1000, 
Chemicon), active caspase 3 (1:1000, Chemicon), p75NTR (1:1000, Chemicon), 
vGAT (1:1000, Synaptic systems), vGLUT1 (1:3000, Synaptic systems), Tuj1 
(1:1000, Sigma), Emx2 (1:500, Sigma), Pax6 (1:1000, an antibody that 
recognizes an epitope in first 223 amino acids,  Developmental Studies 
Hybridoma Bank) RC2 (1:10, Developmental Studies Hybridoma Bank), Mash1 
(1:200, PharMingen), GFP (1:1000, Molecular probes), and Doublecortin 
(1:1000, Santa Cruz). p75NTR intracellular domain (1:2000) (Gschwendtner et 
al., 2003), vGAT (1:1000, Synaptic Systems), and calretinin (1:500, Swant). 
mouse anti-BDNF#940, mouse anti-HA (1:1000, as described8), rabbit anti-p75 
(1:1000, Promega), rabbit anti-p75 (1:1000, Freund I 41, raised against a 
bacterially expressed intracellular domain sequence), rabbit anti-Trk (C-14) 
(1:1000, Santa Cruz Biotechnology), mouse anti-actin (1:5000, Sigma), mouse 
anti-β−ΙΙΙ tubulin (1:5000, Covance), rabbit anti-pPKCα/βΙΙ (Thr638/641) (1:500, 
Cell Signaling), mouse anti-flotillin-1 (1:100,BD transduction laboratories), rabbit 
anti-activated caspase-3 (1:1500, Chemicon). All HRP secondary antibodies 
were obtained from Dianova. Alexa fluorophore-conjugated secondary antibodies 
for immunohisto- and immunocytochemistry were obtained from Millipore. The 
following inhibitors were used at the indicated concentrations: K252a (100 nM, 
tyrosine kinase inhibitor, Calbiochem), Go6983 (7 nM, PKC inhibitor, 
Calbiochem), LY411575 (50 nM, γ-secretase inhibitor), lactacystin (5 μM, 
proteasome inhibitor, Cayman). Recombinant NGF and NT3 produced in 
Chinese hamster ovary cells (CHO) were a gift from Genentech, Inc. 
Recombinant BDNF was produced in E. coli. All neurotrophins were used at a 
final concentration of 50 ng/ml. 
 
Statistical analyses 
Statistical analyses were performed using Student’s t test. Numbers represent 
mean values ± SEM. 
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